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ABSTRACT 
Background: Head and neck cancer is the collective name for cancers that affect the lips, 
oral cavity, nasal cavity, para-nasal sinuses, pharynx, larynx and parotid glands. South 
Africa, as one of the developing countries, is highly affected by the head and neck cancer 
due to lifestyle causes such as smoking and alcohol use. Patients with head and neck cancer 
experience more problems and severe symptoms as a result of the diagnosis and treatment 
as compared to patients diagnosed with other types of cancer. This is due to the fact that 
head and neck cancer affects critical parts of the body which are important for nutrition, 
breathing and communication. Despite the severe consequences of the disease, little is 
known about the experiences of patients living with this disease in South Africa. 
Aim of the study: The study aimed to describe the experiences of patients living with head 
and neck cancer treated at an academic hospital in Gauteng. 
Design and Methods: A descriptive qualitative design was used. The accessible population 
comprised all head and neck cancer patients treated at the study setting. Purposive sampling 
was used to select the sample and the sample size was informed by data saturation. The 
inclusion criteria were 18 years and older, ability to speak basic English and willingness to 
participate. General information was gathered using a demographic data sheet and in-depth 
interviews were conducted to gather the data. The data were analysed by means of 
qualitative content analysis. 
Findings:  Eighteen people (n=18), of which more than half were males (14 of 18), took part 
in the study. The participants were from four major population groups, with the majority from 
the black population (13 of 18). Their ages ranged from 26 to 73, with an average age of 50.8 
years. Five subthemes arose from the data: the emotional effects of the head and neck 
cancer, the physical consequences of the disease and treatment, the socioeconomic 
implications of the disease and treatment, the importance of psychosocial support and the 
importance of hope and spirituality which were categorised into two themes: living with the 
consequences of the disease and treatment and coping with the changed life.  
Conclusion: Living with cancer of the head and neck is not easy. The lives the participants 
knew before they became sick changed and became a living hell. They had to live the effects 
of the disease and treatment, which had a devastating effect on their financial burden. Eating 
became a major challenge and some of the participants struggled to communicate, whilst 
others had to live with facial disfigurement. Some were ridiculed and some isolated 
themselves from social contact. However, receiving support from family and friends and their 
faith in God assisted them to live this changed life. 
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CHAPTER 1 
AN ORIENTATION TO THE STUDY 
 
1.1 INTRODUCTION  
Understanding the experiences of patients during the trajectory of a disease is one of the 
pillars of patient-centred care in cancer patients. Experiences of patients suffering from head 
and neck cancer have been given little attention in South Africa, and Africa as a whole, as 
indicated by the dearth of information available (Maree et al. 2017). Although this matter has 
been given attention in studies done overseas, it is argued that experiences and challenges 
of patients in South Africa are not the same due to different factors such as economic status, 
health systems, geographical factors, the burden of HIV and AIDs (Joshi et al. 2014) and 
poverty (Maree et al. 2017).  This study was therefore designed to gather baseline 
information regarding the experiences of patients with head and neck cancer in the South 
African setting.  
Chapter 1 gives an orientation for the study by presenting the background, the problem 
statement and significance of the study, the research question and objective, and an 
overview of the research design and methods. 
 
1.2 BACKGROUND  
Head and neck cancer is the collective name for cancers that affect the lips, oral cavity, nasal 
cavity, para-nasal sinuses, pharynx, larynx and parotid glands (Mehanna et al. 2011). 
Statistically, head and neck cancer is the sixth leading cancer and number eight in the cause 
of cancer-related deaths in the world. Worldwide, approximately 640 000 people are newly 
diagnosed with head and neck cancer annually, whist causing 350 000 deaths each year 
(Jemal et al. 2011).  
South Africa, as one of the developing countries, is highly affected by head and neck cancer 
due to lifestyle causes, such as smoking and alcohol use (Fagan et al. 2014). According to 
the National Institute for Occupational Health (2011), 4.7% of all males newly diagnosed with 
cancer have head and neck cancer compared to 2% in females. Head and neck cancer has 
the highest incidence among males and is responsible for 7.75% of all cancers in Black 
males, 6.21% in Coloured males, 4.46 % in Asian males and 2.77% in White males. In 
females, the Coloured population has the highest incidence (3.31%) (Singh et al. 2013). 
Head and neck cancer affects people of all age groups, however it is more prevalent among 
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women who are 80 years and above and in men between 60 and 64 years old (Ndui 2011; 
Abram 2013).  
In sub-Saharan Africa, 90% of head and neck cancers affect the oral pharyngeal area 
(Faggons et al. 2015). Tobacco and alcohol use are the main risk factors, however recent 
studies have shown that head and neck cancer is also associated with Human Papilloma 
Virus infection, primarily HPV 16 and 18 (Fagan et al. 2014), which is also responsible for 
most cervical cancers (World Health Organization 2006). However, head and neck cancer 
has some common signs and symptoms, including swelling or a sore in the mouth or nasal 
cavity that does not heal, a red or white patch in the mouth, a mass in the mouth with or 
without pain, hoarseness or change in voice, nasal obstruction or persistent nasal 
congestion, painful or difficulty chewing, ear and/or jaw pain, and loosening of teeth (Galbiatti 
et al. 2013).  
The primary treatments for head and neck cancer are surgery and radiotherapy; 
chemotherapy is mostly added as an adjuvant treatment for patients with advanced disease. 
A multidisciplinary approach is required to be successful in the provision of care and 
treatment of these patients (Galbiatti et al. 2013). The prognosis of patients with head and 
neck cancer is good in the early stages of the disease, whilst advanced stages are 
associated with a poor prognosis (Nekhlyudov et al. 2017). 
According to Farhangfar et al. (2014), patients with head and neck cancer experience more 
problems and severe symptoms as a result of the diagnosis and treatment compared to 
those diagnosed with other types of cancer. This is due to the fact that head and neck cancer 
affects critical parts of the body which are important for nutrition, breathing and 
communication (Itano et al. 2015). Patients with head and neck cancer experience eating-
related problems, such as dysphagia, difficulty chewing, loss of appetite, loss of taste and 
other minor symptoms such as pain, salivation, dry mouth and thick saliva, which result in 
low dietary intake and weight loss (Farhangfar et al. 2014). In addition, these patients 
experience low self-esteem, poor self-image, self-despise, stigma, terror and trauma caused 
by the diagnosis and treatment (Hoole et al. 2015; Isaksson et al. 2016; Threader and 
McCormack 2016). Fear of recurrence is also common (Kanatas et al. 2015). 
 
1.3 PROBLEM STATEMENT  
The research problem for the study relates to patients living with head and neck cancer. Due 
to cancer of the head and neck affecting nutrition, breathing and communication (Lang et al. 
2013; Farhangfar et al. 2014), patients experience unique problems and despite the severe 
consequences of the disease, little is known about the experiences of patients living with this 
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disease in South Africa (Maree and Schmollgruber 2014; Maree et al. 2017). This study 
would provide descriptive summary in its attempt to address the existing knowledge gap. 
 
1.4 RESEARCH QUESTION AND AIM 
The research question for this study was ‘What are the experiences of patients living with 
head and neck cancer treated at an academic hospital in Gauteng?’ 
The study aimed to describe the experiences of patients living with head and neck cancer 
treated at an academic hospital in Gauteng. 
 
1.5 SETTING, RESEARCH DESIGN AND METHODS 
The study was conducted at an academic hospital in Gauteng. A descriptive qualitative 
design (Sandelowski 2000) was used. The target population was all patients treated for 
cancer of the head and neck, whilst the accessible population comprised all head and neck 
cancer patients treated at the study setting. Purposive sampling (Burns and Grove 2010) was 
used to select the sample and the sample size was informed by data saturation(Jolley 2013). 
The inclusion criteria were 18 years and older, ability to speak basic English and willingness 
to participate. General information was gathered using a demographic data sheet (Annexure 
B) and in-depth interviews (Polit and Beck 2014) were conducted to gather the data. The 
data were analysed by means of qualitative content analysis (Sandelowski 2000). 
 
1.6 DEFINITION OF CONCEPTS  
Experience refers to conscious knowledge of physical, emotional, psychosocial and spiritual  
occurrences that are gained through an encounter with an event or disease process (Venes 
2017). It is the process that influences the entire life of an individual or group and usually 
leads to change of behaviour and way of thinking toward life (Boud et al. 2013). 
Head and neck cancer is a collective name for cancers that affect the lips, oral cavity, nasal 
cavity, para-nasal sinuses, pharynx, larynx and parotid glands (Mehanna et al. 2011). 
Anti-cancer treatment refers to any preventative or curative interventions for cancer and its 
associated symptoms (Siegel et al. 2012). For the sake of this study, anti-cancer treatment 
included chemotherapy, radiotherapy, surgery and treatment to control symptoms and side 
effects of the disease and the main treatment.  
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Patient-centred care is an approach that demands the organisation and delivery of 
healthcare based on the patients’ needs by listening to and involving the patient (Rickert 
2012).  
Radiotherapy is a local treatment that involves the use of high energy ionising x-rays to kill 
cancer cells while causing minimal damage to the normal cells (Itano et al. 2015). 
Radiotherapy does not only target cancer cells, hence it causes damage to normal cells, 
resulting in several side effects. The severity of the side effects depends on the site and 
structures involved (Sourati et al. 2017). Radiotherapy can be given as external beam, 
meaning from a distance, or brachytherapy, meaning the radioactive source is placed close 
to the tumour or inside the tumour (Devlin 2015). 
Biotherapy is the use of substances produced from living organisms to modify or augment 
biologic mechanisms against tumour cells (Itano et al. 2015). This is the only treatment 
modality that targets the cancer cells only (Chabner and Longo 2011). 
Palliative treatment refers to the interventions given to cancer patients in order to relieve 
symptoms and improve quality of life without curing the disease (Pennbrant et al. 2015). 
These interventions may include pain control medication, control of tumours to restore 
structural functioning and supportive medication to reduce the effects of the disease on a 
patient’s life (Dunlop 2012). 
 
1.7 OUTLINE OF THE STUDY  
Chapter 1 : Orientation to the study  
Chapter 2 : Literature review  
Chapter 3 : Research methods 
Chapter 4 : Findings and discussion  
Chapter 5 : Justification, limitations and recommendations 
 
1.8 SUMMARY  
Chapter 1 gave an overview for the study, including an introduction, background, the problem 
statement and research question. Furthermore, the research methods, the definition of the 
concepts and an outline of the study were presented. Chapter 2 provides a review of the 
relevant literature related to the study. 
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CHAPTER 2: 
LITERATURE REVIEW 
 
2.1 INTRODUCTION  
Chapter 2 presents a review of literature related to the study. The review included cancer as 
a global burden and an overview of head and neck cancers. With regards to cancer as global 
burden, the focus was on epidemiology, treatment and side effects and survivorship, while 
the overview of head and neck cancer included global and local statics, the anatomy of the 
head and neck, the functions of the structures of the head and neck, etiological factors, 
clinical presentation, histological types and staging, the complications of the disease and 
treatment.   
A search of evidence was done in the following databases and search engines: Science 
Direct, CINHAL, MEDLINE, Google scholar, ProQuest Nursing and Allied Health Source and 
PubMed. The search was limited to articles published between 2010 and 2017, as there was 
a large amount of literature related to research done overseas. The most recent findings 
were reviewed in order to have current understanding of the context of the study. 
A combination of the search terms such as head and neck, cancer, tumours, aero digestive 
region, squamous cell carcinoma, oral, cancer burden, global burden, treatment, signs and 
symptoms, and malignancies were used to search the data bases.  
 
2.2 CANCER AS A GLOBAL BURDEN 
Cancer is a global health problem, and is one of the leading causes of morbidity and death 
globally (Jemal et al. 2011).  
2.2.1 The incidence of cancer 
In 2012, more than 14 million people were newly diagnosed with cancer while over 8 million 
people died from the disease. This is an increase in the global burden of cancer compared to 
the 2008 statistics, when approximately 12.7 million people were newly diagnosed  and 7.1 
million deaths occurred due to cancer (Torre et al. 2015). The trend shows that the incidence 
of cancer has remained the highest in the developed world, while the mortality rate is the 
highest in the developing world (Siegel et al. 2013). According to Siegel et al. (2013), more 
than 5 million of the 8.1 million cancer related deaths were from the developing world, 
indicating a high cancer mortality in the developing world compared to the developed world. 
The high mortality rate of cancer patients in the developing world is attributed to under-
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developed health systems, a lack of resources (both human and material), high poverty 
levels and the increased burden of HIV and AIDS (Joshi et al. 2014). According to Torre et 
al. (2015), the five-year survival rate of all cancers worldwide is estimated in the range of 40 
to 67%. People of all age groups are equally affected by different types of malignancies. 
Sub-Saharan Africa, as part of the developing world, is hard hit by the burden of cancer. 
Sub-Saharan African women are mostly affected by malignancies of the breast and cervix, 
accounting for approximately 50% of all cancers in women, whilst men are mostly diagnosed 
with cancers of the prostate, Kaposi’ sarcoma and liver cancer, representing more than 45% 
of all malignancies diagnosed in men (Ferlay et al. 2014; Olaleye and Ekrikpo 2017). 
Approximately 3% of Sub-Saharan African women will develop cancer of the cervix and 
breast, whilst more than 2% of those diagnosed will die. Conversely, approximately 3% of 
men develop prostate cancer in their life time, with a case fatality ratio of 1:50 (Ferlay et al. 
2014; Parkin et al. 2014).  
The Republic of South Africa is one of the countries where lifestyle factors such as smoking 
and drinking alcohol contribute to an increase in the prevalence of cancer in the population. 
According to the Cancer Association of South Africa (2017), more than 14% of South African 
men are at risk of developing cancer, while nearly 12% of women are likely to develop 
cancer. The risk of developing cancer is the highest among Coloured and White men (25% 
each group) compared to the rest of the racial groups, while in women, the risk is highest 
among White women (20%) followed by Asian and Coloured women, with life time risk of 
approximately 14% in each group (National Institute for Occupational Health 2011). Prostate 
cancer is the number one cancer in South African men, accounting for approximately three in 
every 20 men with cancer, while breast cancer is responsible for more than 20% of all 
cancers in women (Cancer Association of South Africa 2017).  In all racial groups, cancer of 
the prostate is the most prevalent in men, whilst women are mostly affected by breast 
cancer, except for Black women who suffer most commonly from cervical cancer (Cancer 
Association of South Africa 2017). According to the Cancer Association of South Africa 
(2017), an estimated 46% of all cancer deaths in the general population are caused by 
malignancies of the lung, oesophagus, cervix and breast. Lung, oesophageal and prostate 
cancers are the main causes of cancer-related deaths in men, accounting for an estimated 
50%. Most of the cancer-related deaths in South African women are caused by cervix, 
breast, lung, oesophagus and colorectal cancers, accounting for more than 60% of all cancer 
deaths. 
2.2.2 Causative factors  
A number of studies have reported three major causes of cancer worldwide, tobacco, alcohol 
and infection by viruses (Bravi et al. 2014; Pytynia et al. 2014; Shingler et al. 2017). 
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Tobacco is the main cause of several cancers in the world and is attributed to an increased 
percentage of cancer-related death. Almost all patients diagnosed with lung cancer have a 
history of tobacco use of some kind, or have had exposure to secondary smoking. 
Approximately seven in every 10 lung cancer deaths in the developing world are attributed to 
tobacco and around 20% of the world cancer deaths are caused by tobacco (Torre et al. 
2015). In addition, cancers of the head and neck and oesophagus have been highly 
associated with cigarette smoking or exposure to it (Shingler et al. 2017). Chiaffarino et al. 
(2016) also reported a strong association between tobacco use and an increased risk for 
gynaecological cancers such as uterine myoma and cervical cancer. Furthermore, the risk of 
developing oesophageal cancer is high among smokers compared to non-smokers (Oze et 
al. 2011). According to the review and meta-analysis conducted by Leonardi-Bee et al. 
(2012), smokers are at a greater risk for the development of cutaneous squamous cell skin 
cancer than their counterparts. Another systemic review of cohort and case control studies 
regarding the major risk factors for pancreatic cancer also singled out tobacco as the 
predominant risk factor (Matsuo et al. 2011).    
Alcohol on its own is carcinogenic in nature and is associated with different anatomic site-
specific malignancies. Alcohol use is responsible for approximately 4% of global cancer-
related deaths (Nelson et al. 2013).  People who drink alcohol heavily are more than three 
times at risk of developing cancers of the head and neck, especially the malignancies of the 
oral cavity, larynx and pharynx (Bagnardi et al. 2015). Alcohol on its own is the number one 
cause of tumours of the oesophagus and a standalone causative factor of cancer of the liver 
(Grewal and Viswanathen 2012; Bagnardi et al. 2015). In a number of studies related to 
alcohol as the causative factor for breast cancer, researchers have reported an increased 
risk of breast cancer amongst women who drink compared to non-drinkers (Bagnardi et al. 
2015). Fedirko et al. (2011), in a meta-analysis, also reported a direct proportional increase 
of risk for colorectal cancer associated with the increase in alcohol intake. 
Approximately 20% of all cancers diagnosed in the world are caused by infections, such as 
viruses (Jacqueline et al. 2017). There are a number of viruses that cause different human 
cancers including hepatitis B and C virus, human papilloma virus (HPV), Epstein-Barr virus 
(EBV), Kaposi's sarcoma-associated herpes virus (KSHV) and Merkel cell polyoma virus 
(Jacqueline et al. 2017). Shiels et al. (2011) reported a number of cancers that are directly 
associated with Human Immunodeficiency Virus infection, mainly Kaposi’s sarcoma and non-
Hodgkin’s lymphoma. Human papilloma virus is an established cause of several 
gynaecological cancers, such as cervix, vulva and vagina, as well as penis cancer. Pytynia et 
al. (2014) reported an increased incidence of oropharyngeal cancers among patients who 
were infected by human papilloma virus, which concurs with the research results reported by 
Vokes et al. (2015). 
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2.2.3 Treatment modalities 
The goals of cancer treatment are cure, control, palliative and supportive care (Siegel et al. 
2012). A number of treatment modalities are used to treat the disease, including 
radiotherapy, surgery, biotherapy and chemotherapy (Itano et al. 2015).  
More than 60% of cancer patients are treated with radiotherapy along their disease 
continuum (Miller et al. 2016). According to Itano et al. (2015), cancer patients can receive 
radiotherapy as either primary therapy, neoadjuvant or adjuvant therapy. Early stages of 
cancer have been associated with a high cure rate when treated with radiotherapy, while the 
late stages require more than one treatment modality to produce successful results (Miller et 
al. 2016). 
In certain types of cancers, and in advanced stages of cancer where cure may not be 
possible, radiotherapy can be administered to control tumour growth, thereby controlling 
disease progression for a duration of time from months to years. The use of brachytherapy 
along with external beam radiation has been associated with good patient outcome in 
patients with cancer of the breast, prostate and the head and neck (Itano et al. 2015). 
Although radiotherapy is intended to kill cancer cells, it has lethal effects on normal cells, 
which may be acute or late. Nearly all patients who receive radiotherapy will report general 
acute side effects, such as fatigue and skin reactions, which compromise their quality of life 
(Itano et al. 2015; Bray et al. 2016). These undesirable effects can be distressing and 
incapacitating to the patients, depending on the severity. In addition, research has reported 
severe acute and late site-specific side effects of radiotherapy, such as alopecia in relation to 
brain irradiation, oral mucositis in relation to the head and neck, and vaginal dryness, 
diarrhoea and cystitis related to pelvic irradiation (Radvansky et al. 2013; Bray et al. 2016; 
Kole et al. 2017). 
Amongst the interventions that have been developed, none have proven effective in 
completely preventing these distressing side effects, only lessening the severity (Di Franco et 
al. 2013).  The knowledge of the relationship between the dose of radiotherapy and the 
severity of the side effects has resulted in the discovery of fractionation of the dose to reduce 
the lethal impact on the normal cells (Modesto et al. 2012). In addition, patients are generally 
advised on skin care practices, which only help in lessening the severity and preventing 
complications (Itano et al. 2015). Clinical experiments have revealed that fractionated 
radiotherapy is associated with reduced damage to the normal tissue and more damage to 
the tumour cells, hence less side effects with increased cure rate (Wong et al. 2013). The 
other measure to reduce the fatal outcomes of radiotherapy is pre-treatment assessment to 
rule out the risk factors that may aggravate radiotherapy-induced side effects, such as poor 
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performance status and comorbidities (Modesto et al. 2012). Scientific investigations have 
shown that patients with poor performance status and who have a comorbidity often do not 
respond well to treatment compared to those with good performance status (Chan et al. 
2014). 
Radiotherapy in combination with chemotherapy or surgery has proven effective in treating 
many cancers with a good cure rate, however in many scientific investigations, patients have 
reported multiple severe acute and late side effects compared to radiotherapy alone (Kole et 
al. 2017). 
 Chemotherapy is the most common treatment modality widely used globally to treat different 
cancers. Unlike radiotherapy and surgery, which are localised treatments, chemotherapeutic 
agents are administered through the cardiovascular system to reach the tumour site, hence 
the name ‘systemic treatment’ (Siegel et al. 2012). Chemotherapy can be used as primary 
treatment as a single treatment modality, or in combination with other treatment modalities as 
an adjuvant or neoadjuvant treatment (Chabner and Longo 2011). The use of more than one 
chemotherapeutic agent with different modes of action in combination to treat cancer is an 
effective way of killing many cancer cells at different stages of the cell cycle (Miller et al. 
2016). Apart from cure, some patients receive this treatment just to control the growth of 
tumour or to relieve the cancer-related symptoms, such as pain, depending on the stage of 
the disease (Mañós et al. 2017).  
The fact chemotherapy does not only target cancer cells but also the normal rapidly dividing 
cells, results in a number of associated problems ranging from acute to late side effects, 
such as mucositis, cystitis, alopecia, myelosuppression and hand-foot syndrome (Itano et al. 
2015). Side effects resulting from chemotherapy are not tumour site-specific for the reason 
that it is a systemic treatment (Siegel et al. 2012).  
If the tumour is localised to a small area and can be removed without causing major 
complications, surgery can be utilised. Oncological uses of surgery, based on the purpose of 
the procedure, are treatment of the disease, diagnosis and staging, relief of symptoms, 
reconstruction and rehabilitation (Itano et al. 2015). Like any other treatment modality, 
surgery causes undesirable side effects, such as disfigurement, acute or chronic pain, loss of 
function of body parts, lymphoedema, organ damage and loss of body image (Galbiatti et al. 
2013). 
Laboratory research regarding the chemical processes within the tumour cells has led to the 
discovery of yet another treatment modality known as targeted therapies and biotherapies, 
which target the specific processes within the tumour cells and augment the immune system 
against cancer cells (Miller et al. 2016). Kawalec et al. (2012) in a systemic review reported 
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an increased survival rate and reduced side effects among the patients treated with targeted 
therapy. According to the American Cancer Society (2016), targeted therapy and biotherapy 
are effective treatments for a number of malignancies. Many of these therapies have been 
approved by the Food and Drug Administration for diagnosis, treatment and supportive 
therapy in cancer patients. Targeted therapy and biotherapy can be used as primary 
treatment in combination with other modalities, or as a single agent (Miller et al. 2016). 
2.2.4 Survivorship in cancer patients 
The term survivorship is used for the ability to meet bio-psychosocial needs in order to 
maintain health and quality of life beyond the diagnosis of cancer, to the end of life (Ringash 
2015). According to the National Cancer Institute’s dictionaries, cancer survivorship is 
concerned with how healthy life is lived after diagnosis and treatment of cancer including the 
impact of cancer on the psychosocial, economic and physiological domains of life (National 
Cancer Institute 2016). Cancer survivorship is also defined as the life experiences of cancer 
patients from diagnosis of the disease, throughout treatment and beyond the disease 
(Cancer. Net 2016) and includes follow-up treatment and healthcare, quality and quantity of 
life issues and late side effects of treatment. Itano et al. (2015) grouped these survivors into 
three main categories, which includes those who have just begun the treatment, those who 
are recovering and adapting to a new normal and those who are living with lifelong needs. 
Patients present with different and unique needs at each phase of survivorship. The current 
focus of survivorship is on the quality of life through management of disease and the 
treatment related side effects, and early detection of recurrent disease, while psychosocial 
and socio-economic needs of the patients are usually overlooked. 
Around 12 million cancer patients survive over five years globally (Jacobs and Shulman 
2017). Cancer survivors still live with the aftermaths of cancer and its aggressive treatments, 
which may result in increased survivorship needs (Siegel et al. 2012). The major concerns of 
cancer survivors are the fear that cancer might come back, late side effects of treatment and 
the challenge of facing a new life following the incapacitation caused by cancer and 
treatment (Ghazali et al. 2013). Conversely, the partners and family members of cancer 
survivors are concerned with life changes in their partners, which influences the way they 
relate to them, yet survivorship support is mainly focused on the patients (Turner et al. 2013). 
Young cancer survivors are mostly affected by psychosocial and fertility issues (Watson et al. 
2016) and Howard-Anderson et al. (2012) reported the need to address fertility issues and 
physical inactivity, as they are major concerns among young cancer survivors. Psychosocial 
needs of cancer survivors are mostly neglected, yet they are the major determinants of 
quality of life among cancer survivors (Watson et al. 2016).  
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Health and quality of life during the survivorship period depends on the patient’s related 
factors. Survivors who engage in health-promoting behaviour, such as physical activities, live 
a healthier life compared to those who live a sedentary life, however the level of activity is 
related to level of individual ability (Garcia and Thomson 2014). According to Becker et al. 
(2012), comorbidities negatively influence the outcomes of survivorship as cancer survivors 
with comorbidities live with poor quality of life and shortened life expectancy. 
Survivorship care for cancer survivors has been in place since 1986 however, there are still 
challenges to meet the needs of the cancer survivors. Jacobs and Shulman (2017) identified 
care coordination, shortage of health professionals, lack of knowledge by practitioners and 
quality and cost of care as some of the challenges to meet the needs of cancers survivors. 
 
2.3 AN OVERVIEW OF HEAD AND NECK CANCER 
Head and neck cancers are the notorious cancers of the aero digestive region, which 
includes the pharynx, nasal cavity, paranasal sinuses, oral cavity, saliva gland and the larynx 
(Jemal et al. 2011). These cancers affect the vital anatomical parts, which are responsible for 
life-supporting physiological processes such as breathing, nutrition and verbal 
communication.  
2.3.1 Incidence of head and neck cancer 
Head and neck cancer is in sixth position on the list of leading cancers worldwide, but it is 
one of the deadliest cancers due to the importance of the anatomical structures involved 
(Bose et al. 2013). Approximately 650,000 people are newly diagnosed, while 350,000 
people die of head and neck cancer each year globally (Gupta et al. 2016). Cancer of the 
head and neck constitutes 4% of all cancers worldwide and the burden of the disease is 
three times more common in males than in females (Jain et al. 2013). Bose et al. (2013) 
described the most common sites affected by head and neck cancer as the oral cavity, larynx 
and oropharynx, and 90% of these cancers start from squamous cells, hence they are 
commonly known as squamous cell carcinoma of the head and neck. The disease is at its 
peak among people between 50 and 70 years of age. Approximately, 4% (27,953) of all 
cancers in Africa are head and neck cancers, whilst more than 65% (18,835) of these 
patients die each year. The ratio of male to female remains close to that of the world, ranging 
from 0.5:1 to 1:4.  
South Africa, as one of the developing countries, is highly affected by head and neck cancer 
due to life style factors, such as smoking and alcohol use (Fagan, Stannard and Dalvie, 
2014). Tumours of the head and neck constitute more than 5% (4,045) of all cancers in the 
South African population, causing 1815 deaths each year. The most common sub-anatomic 
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site for the disease remains the oral cavity, followed by the larynx and the nasopharynx. 
According to the National Institute for Occupational Health (2011), 4.7% of all males newly 
diagnosed with cancer have head and neck cancer, compared to 2% in females. The disease 
has the highest incidence among males and is responsible for 7.75% of all cancers in Black 
males, 6.21% in Coloured males, 4.46 % in Asian males and 2.77% in White males. In 
females, the Coloured population has the highest incidence (3.31%) (National Institute for 
Occupational Health 2011; Singh et al. 2013). Head and neck malignancies affect people of 
all age groups, however it is more prevalent among women who are 80 years and older and 
among men between 60 and 64 years old (Ndui 2011; Abram 2013).  
2.3.2 The structures of the Head and neck 
The region of the head and neck comprises the oral cavity, pharynx, nasal cavity, paranasal 
sinuses, larynx, salivary gland and the tongue (Bose et al. 2013), as shown in the Figure 1 
below. 
 
Figure 1: The head and neck cancer anatomical sites.  
Source: National Cancer Institute (2017) 
The oral cavity encompasses the lips, oral mucosa, anterior two thirds of the tongue, upper 
and lower alveoli, hard palate, floor of the mouth and retro molar trigone (Galbiatti et al. 
2013) and also includes four pairs of the salivary glands, which are located in the different 
anatomical sites. The parotid glands are situated between the jaw and ear, submandibular 
glands are under the mandible or jaw bone, the sublingual glands are found on the floor of 
the mouth under the tongue and the buccal glands are found in the mucous membrane 
covering the oral cavity (Bose et al. 2013). The nasal cavity and paranasal sinuses 
encompasses the inner walls of the nostrils, the nasal vestibule, ethmoid and frontal sinuses, 
single sphenoid sinus and frontal sinuses (Gupta et al. 2016).  
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The pharynx is made up of three main anatomical sites, the nasopharynx, oropharynx and 
hypopharynx (Bose et al. 2013). The nasopharynx is the posterior wall behind the nasal 
cavity, while the oropharynx includes the base of the tongue, soft palate, posterior 
pharyngeal wall and tonsils. The inferior part of the pharynx is the hypopharynx, which 
makes up the posterior wall of the larynx.  
The larynx,  which is shielded by the thyroid cartilage, is from the epiglottis to the cricoid 
cartilage (Itano et al. 2015) and includes the supra-glottis, the glottis and sub-glottis (Gupta 
et al. 2016).  
There are other vital anatomical structures around this area, but they are not categorised as 
part of the head and neck. These include the oesophagus, thyroid gland, parathyroid glands, 
the ears, bones and the eyes, which are likely to be affected by either cancer of the head and 
neck or the treatment (Gupta et al. 2016). The head and neck is also drained by a number of 
lymph nodes, including the pre- and post-auricular nodes, submandibular, submental, deep 
and superficial cervical chains, the tonsillar nodes and the occipital nodes. These lymph 
nodes become the first victims of head and neck cancer (Bose et al. 2013).  
2.3.3 The life supporting functions of the head and neck region 
The structures of the head and neck form the upper part of the respiratory system, which 
provides access to the external environment (Itano et al. 2015). These structures are 
responsible for removing dust and other particles from the inhaled air, providing warmth and 
moisture to the air before it reaches the lungs (Bose et al. 2013) and protecting the lungs 
from microorganisms and foreign bodies by trapping them using mucus and hair present in 
the nasal cavity and nasopharynx. 
The olfactory nerves insert on the mucosa of the nasopharynx, which communicates with the 
olfactory cells within the mucosa, serves as the receptor for smell; this function helps to 
differentiate and classify different kinds of smells (Bose et al. 2013). The tumours of the 
nasopharynx or paranasal sinuses or associated treatment to these areas result in 
alterations or loss of sense of smell. 
Speech is another important process that is a product of coordinated functions of the larynx, 
pharynx, mouth, nose and paranasal sinuses. These structures coordinate to form speech in 
three phases - phonation, articulation and resonation. Any cancer affecting these structures 
causes speech problems, or sometimes a complete loss of speech especially in 
malignancies of the larynx (Heijnen et al. 2016).  
The anatomical structures of the head and neck also serve a nutritional function, whereby the 
oral cavity and oropharynx are the important structures for mastication and deglutination of 
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food (Itano et al. 2015). These processes cannot be possible if the structures are diseased, 
making it difficult for the person to ingest food via the mouth, resulting in malnutrition 
(Farhangfar et al. 2014). 
The tongue is the only anatomical site where a sense of taste is accomplished. This function 
is achieved through the presence of taste buds on the tongue and other sites within the 
mouth, which are enervated by the trigeminal nerve (Bose et al. 2013). The trigeminal nerve 
is responsible for transmitting taste sensation to the gustatory cortex in the brain from the 
taste buds present on the tongue, roof of the mouth, sides of the mouth and in the throat 
(Itano et al. 2015). The most common causes of taste alteration or loss include malignancies 
of the tongue and treatment-related side effects such as surgery and radiotherapy to the 
head and neck (Isaksson et al. 2016).  
The salivary glands, as described by Bose et al. (2013), are responsible for the production of 
saliva which serves to keep the mouth moist, to moisten dry food and to cool hot food. The 
saliva also contains the enzyme called saliva amylase, which is important for breaking down 
carbohydrates. Cancer of salivary glands or the treatment, such as radiation to the head and 
neck, can compromise the function of the glands resulting in xerostomia (Radvansky et al. 
2013).   
The thyroid and parathyroid glands are located in the area of the head and neck, as 
described earlier, and these glands produce thyroxine, calcitonin and parathyroid hormones 
(Bose et al. 2013). Thyroxine controls metabolism and acts as a growth factor for bone 
growth, while calcitonin and parathyroid hormones are responsible for regulation of calcium 
in the body (Itano et al. 2015). Either the head and neck tumours or the treatment’s side 
effects can affect normal functioning of the above mentioned glands, resulting in disruption in 
hormonal regulation and electrolyte imbalance (Farhangfar et al. 2014).   
2.3.4 Clinical Presentation  
Patients experience signs and symptoms of head and neck cancer differently depending on 
the anatomical site from which the cancer arises (Itano et al. 2015). However, the common 
clinical signs and symptoms reported by patients are a lump or sore in the mouth that refuses 
to heal, difficulty with breathing, difficulty with swallowing, nasal bleeding, persistent nasal 
congestion, change of taste and unexplained change in voice (Galbiatti et al. 2013).  
2.3.5 Histological classification of the disease 
Histologically, the most common type of head and neck cancer is squamous cell carcinoma, 
which begins in the epithelial cells of the mucosa lining region (Bose et al. 2013). 
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Approximately 90% of patients are diagnosed with squamous cell cancer, while 10% present 
with adenocarcinoma or sarcoma (Jemal et al. 2011).  
2.3.6 Staging of the disease 
Like other tumours, staging of the head and neck cancers is based on the tumour size, 
number of lymph nodes involved and metastasis (TNM) (Gupta et al. 2016). Once the tumour 
is found, measurements are taken and the size is denoted by T followed by a number 
between 1 and 4 to represent the size of the tumour (D’cruz et al. 2013). Estimating the size 
of the tumour can be done clinically and a more accurate description can be done through 
computerised scans. 
The cancers of the head and neck are likely to spread to the lymph nodes around the neck 
and the lungs. The number of lymph nodes involved influences the staging of the disease 
and is represented by N and a number between 1 and 4 to indicate how many nodes are 
involved. Patients who have had metastasis to the cervical nodes are more likely to develop 
another head and neck cancer after treatment (Deschler et al. 2014). Patients who have 
metastasis to the cervical nodes, compared to those who do not, have a reduced five-year 
survival rate, a reduction of approximately half (Huang and O’Sullivan 2017).  
The staging for the disease is also measured by metastasis, whereby the presence of distant 
metastasis is denoted by M1, while its absence is represented by M0 (Galbiatti et al. 2013). 
Commonly, patients are diagnosed with the disease as a result of metastasis of cancers from 
other sites, such as breast, lung or the bowels, and it is recommended that head and neck 
cancer patients should be examined for the possibility of primary cancers from other sites 
(Bose et al. 2013). However, the disease has a common trend of metastasis and the most 
common anatomical regions that are affected are the lungs, breasts and the brain (Itano et 
al. 2015).  
2.3.7 Etiological factors   
A number of investigations have pointed out that tobacco and alcohol remain the major 
causes of head and neck cancer. Approximately 75% of head and neck cancers are caused 
by alcohol and tobacco use (Galbiatti et al. 2013). Different forms of tobacco use are 
attributed to different cancers of the specific anatomical sites in the head and neck area 
(Shingler et al. 2017). People who sniff or chew tobacco are prone to cancers of the 
nasopharyngeal and oral cavity areas respectively, while those who smoke tobacco are at 
high risk of developing cancer of the larynx, lips, oral cavity and oropharynx (Koyanagi et al. 
2016). People who use tobacco are 25 times more likely to develop the disease compared to 
those who do not and those who consume excessive alcohol are nine times more at risk 
compared to those who do not drink alcohol (Bagnardi et al. 2015). According to Galbiatti et 
 16 
 
al. (2013), a combination of these two risk factors poses a greater risk for the disease 
compared to one risk factor alone; people who use both tobacco and alcohol are at greater 
risk of developing this disease than those who use one or the other.   
The increase in prevalence of head and neck cancer among non-smokers and young people 
has attracted the attention of researchers to discover viral infections as the cause of the 
disease. Recent studies have shown that infection with the human papilloma virus, especially 
types 16 and 18, increases the risk of developing malignancies of the head and neck area 
(Vokes et al. 2015). In a genetic study regarding the differences between HPV positive and 
HPV negative head and neck tumours, Seiwert et al. (2015) reported significant differences 
in the genetic mutations and the genes that are involved, which clearly indicates that HPV is 
an important risk factor. Globally, the incidence of HPV positive oropharyngeal cancers has 
roughly increased 20-fold, with an alarming increase of approximately 65% in North America 
(Gupta et al. 2016). Pytynia et al. (2014) reported that HPV is commonly the cause of 
specific cancers of the oropharynx, which include the base of the tongue, soft palate and the 
tonsils. According to Forte et al. (2012), the clear trends of HPV- associated oropharyngeal 
tumours can be understood when cancers of the oropharynx are examined separately from 
the rest of the head and neck cancers. According to Dayyani et al. (2010), HPV- associated 
carcinomas of the head and neck are more sensitive to chemo-radiation with good prognosis 
and increased survivor rate compared to tobacco and alcohol associated disease.  
Rettig et al. (2015) and Shah et al. (2017) reported that the practices of oral-genital sex and 
multiple sex partners are high among patients with HPV-related oropharyngeal cancers, 
which denotes that these behaviours increase the infection rate of HPV resulting in increased 
prevalence of HPV related disease. However, researchers have observed that more than 
60% of HPV positive oropharyngeal cancer patients are either exposed to tobacco or are 
previous smokers, and the trend of HPV-related disease among men and women is 3:1, 
which is no different to the trend in tobacco and alcohol-related disease suggesting that HPV 
is not fully understood as a risk factor for head and neck carcinomas (Forte et al. 2012). 
2.3.8 Treatment of head and neck cancer  
Depending on the stage of the disease at the time of diagnosis, head and neck cancers are 
curable. The important treatment options available for the disease include surgery, 
radiotherapy and chemotherapy. To make a decision regarding the best treatment modality 
to use depends on factors such as the location of the tumour, stage and type of the disease, 
and the anticipated side effects of the disease (Galbiatti et al. 2013). According to Gupta et 
al. (2016), more than 60% of patients diagnosed in the early stages of head and neck cancer 
respond well to local treatment while those diagnosed in the late stages require combined 
treatment modalities. The treatment decisions for carcinomas of the head and neck require a 
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multidisciplinary approach to minimise treatment-related side effects and improve the 
patient’s quality of life after treatment (Mañós et al. 2017).  
2.3.9 Complications of the disease and associated treatment 
Head and neck cancer and its treatment are associated with a number of complications 
which may be life threatening and lifelong. Nearly all patients who are affected by tumours of 
the pharynx will experience airway obstruction requiring lifelong tracheostomy (Galbiatti et al. 
2013). Most of these patients with cancers of other sites of the head and neck, other than the 
larynx, also lose the ability to articulate words properly and eventually they lose speech as 
the disease progresses (Heijnen et al. 2016). Usually, cancers of the oral cavity, 
nasopharynx, pharynx and nasal cavity interfere with patient’s ability to chew and swallow, 
resulting in patients surviving with a gastric tube (Paccagnella et al. 2010). 
Patients who undergo surgery are likely to live with the aftermath. During surgical 
procedures, nerves and lymph vessels may be destroyed or cut, resulting in numbness and 
oedema around the neck and throat, which may affect swallowing (Gupta et al. 2016). 
According to Galbiatti et al. (2013), major surgery for tumours of the head and neck causes 
disfigurement, resulting in a change of appearance. Laryngectomy, which is surgical removal 
of the larynx for treatment of cancer of the larynx, usually causes the patients to permanently 
lose their voices, which is a big challenge to human interaction (D’cruz et al. 2013). Some 
major operations involving the ear or eye can result in a loss of function of these organs, 
which may be temporary  or permanent (Deschler et al. 2014). Cooper et al. (2012) reported 
that surgery to the head and neck area often results in a patient having lifelong or acute 
difficulties in chewing and dysphagia, and eventually they live with a gastric tube for feeding 
for the rest of their lives. Nearly all patients who undergo a total laryngectomy will develop 
serious metabolic problems, such as hypothyroidism and calcium imbalance, due to the 
involvement of the thyroid and parathyroid glands (Cooper et al. 2012).  
Patients who are treated with radiotherapy usually present with severe specific side effects 
due to the delicacy of the anatomical structures involved. According to Radvansky et al. 
(2013), patients who receive radiotherapy for tumours of the aero-digestive region often 
report taste changes, dysphagia or voice changes due to the lethal effects of radiation on 
normal cells in this region. Often patients complain of xerostomia and mucositis, which are 
very distressing symptoms, resulting in reduced oral intake (Radvansky et al. 2013). Usually 
patients who are treated for cancer of the paranasal sinuses, nasopharynx and nasal cavity 
will complain of earache, or loss of hearing and sight due to the involvement of the ear and 
eye in the field of radiation (Reyes–Gibby et al. 2017), which results in the death of normal 
cells within these organs. Studies have also shown that patients receiving radiotherapy for 
cancer of the larynx are likely to develop hypothyroidism three to four weeks post treatment, 
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related to the damage of the thyroid gland by radiotherapy (Gupta et al. 2016). Heijnen et al. 
(2016) also reported trismus as one of the serious late side effects of radiotherapy caused by 
scarring of muscles of mastication due to the effects of radiotherapy.  
2.3.10 Survivorship Issues   
Current statics have shown that the number of survivors from head and neck cancers has 
increased worldwide due to improvements in treatment modalities (Ringash 2015). Survivors 
from malignancies of the head and neck area are a unique group with complex needs due to 
the complications associated with the disease and treatment (Becker et al. 2012). Simcock 
and Simo (2016) reported the uniqueness of these survivors is that most live with artificial 
life-supporting structures, such as tracheostomy or feeding tubes, resulting in changes in 
lifestyle that affect all spheres of their life.  
Approximately, 68% of head and neck cancer survivors live with needs that require attention 
from health professionals and the most common identified needs are related to psychological 
and physical domains (Nekhlyudov et al. 2017). In another survey regarding unmet needs 
among head and neck cancer survivors, more than half of the patients reported at least one 
need that required attention (Ringash 2015). Simcock and Simo (2016) identified the most 
common needs presented by head and neck cancer survivors as psychosocial and 
physiological, which persist from diagnosis to beyond treatment. Siegel et al. (2012) reported 
most psychosocial and physical needs among survivors of head and neck malignancies are 
due to disease and treatment-related complications, such as permanent hearing loss, loss of 
speech, fatigue, disfigurement and financial costs. Mostly, the psychosocial and physiological 
domains are highly rated attributes of quality of life among survivors of tumours of the head 
and neck, with most of the needs arising from the psychosocial domain (Cohen et al. 2016). 
However, evidence has shown that health professionals prioritise physical problems and 
disease control as most important issues while patients’ psychosocial needs remain unmet 
(Becker et al. 2012). 
In a literature review, Pulte and Brenner (2010) reported that the overall five-year survival 
rate for head and neck cancer improved by more than 10% in the 14-year period from 1992 
to 2006. However, most patients who continue drinking and smoking during and after 
treatment will not live for five years (Becker et al. 2012). Continued drinking and smoking 
during and after treatment have also been associated with high risk for recurrence of the 
disease and poor prognosis (Simcock and Simo 2016). In a study to compare five-year 
survival rates, Dayyani et al. (2010) reported a good prognosis and an increased survival 
rate in HPV-associated tumours compared to those related to tobacco and alcohol. 
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2.4 SUMMARY  
Chapter 2 presented a literature review regarding cancer as a global, sub-Saharan and 
South African problem, with the focus on head and neck cancer. The focus on head and 
neck cancer included statistics, anatomical site and function, the predisposing factors, 
staging and treatment, the side effects of the disease and treatment and survivorship. 
Chapter 3 will discuss the research design and methods. 
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CHAPTER 3: 
RESEARCH DESIGN AND METHODS 
 
3.1 INTRODUCTION 
Chapter 3 will discuss the research design and methods that were used to answer the 
research question. Research methods are a framework for data gathering, management and 
analysis of data including trustworthiness and ethical considerations (Smith 2015). Therefore, 
this chapter presented the research design, population and sampling, data gathering 
process, data analysis, ethical considerations and trustworthiness.  
 
3.2 RESEARCH SETTING  
The study setting is defined as a description of the location or the environment in which the 
study is done (Burns and Grove 2010). The study setting was an academic hospital in the 
Gauteng Province, which provides highly specialised services and serves as referral hospital 
for regional hospitals, neighbouring hospitals and patients from the rest of Africa. According 
to South African Doctors (2017), the hospital has a capacity of 1088 beds and over 4,000 
professionals and support staff. The hospital has 18 clinical departments and allied medical 
departments. The hospital provides specialised services for Oncology, Nephrology, Trauma, 
Cardiology, Intensive Care, Surgery, Obstetrics and Gynaecology. Various departments, 
including the Adult and Paediatric Oncology Departments are centres of excellence(Gauteng 
Provincial Government 2014). The hospital is a training institution for both undergraduate 
and postgraduate students from the University of Witwatersrand, Faculty of Health Sciences 
and other universities and colleges in the Gauteng Province. According to the Gauteng 
Provincial Government (2014), the Radiation Oncology Department is the largest oncology 
facility in South Africa and treats approximately 3,500 cancer patients per year. The hospital 
provides brachytherapy, external beam therapy, chemotherapy and surgery for cancer 
patients. 
 
3.3 RESEARCH DESIGN 
The research design is the main framework that guides the selection of suitable research 
methods to answer the research question in a study (Wahyuni 2012). It helps the researcher 
choose the suitable sample and sampling method, data gathering tools, data analysis 
method and methods of ensuring trustworthiness in a study (Yin 2013). In this study, a 
descriptive qualitative design was used to answer the research question. According to 
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Sandelowski (2000) and Polit and Beck (2012), qualitative description is a method that aims 
at giving a comprehensive summary of events surrounding a phenomenon with no intention 
of interpretation. Sandelowski (2010) recommends the use of qualitative description in 
situations where little is known about a phenomenon, in order to gather baseline data for 
further research.   
Sandelowski (2000) considers qualitative description as the “least theoretical in the spectrum 
of qualitative approaches” [p. 337], as this approach is the least burdened by pre-existing 
theories such as philosophies. Qualitative descriptive studies support the beliefs of 
naturalistic enquiry where there is no pre-selection or manipulation of variables and no prior 
commitment to any theoretical or philosophical view. Using a descriptive qualitative design 
allowed the researcher to provide baseline data pertaining to the experiences of patients 
living with cancer of the head and neck without the influence of a pre-existing theoretical 
framework. 
  
3.4 POPULATION AND SAMPLING 
A research population refers to a group of individuals or objects with similar characteristics 
on which the study is focused (Polit and Beck 2012). The population is described in terms of 
a target and an accessible population. The target population is a group of individuals with 
characteristics to which the study conclusions are inferred, while the accessible population is 
a group of individuals which meet the selection criteria and are accessible to the researcher 
(Banerjee and Chaudhury 2010). The target population for this study comprised all patients 
diagnosed with cancer of the head and neck, while the accessible population were all head 
and neck cancer patients who were treated at the hospital where the study was conducted. 
The inclusion criteria were being treated and completed treatment for head and neck cancer, 
18 years and older, the ability to speak basic (simple) English and willing to participate in the 
study.    
A sample is defined as a manageable portion of the population that is used in a study to 
describe the characteristics of interest to represent the whole population. A sample size 
refers to the number of participants required for the sample. The sample for this study was 
determined by data saturation, a point where adding more participants would result in 
redundancy of information (Polit and Beck 2012). Data saturation defines the sample limit in 
qualitative studies because adding more participants after data saturation does not add any 
value to the research results (Fusch and Ness 2015). Data saturation was reached after 18 
interviews and the sample size was therefore 18 (n=18). 
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Sampling is a method used to recruit participants for the study, selected based on suitability 
to the design of the study (Suri 2011). Purposive sampling, which is a non-probability 
sampling technique in which the participants are selected by the researcher based on the 
characteristics of the population and the objective of the study (Polit and Beck 2014), was 
used to select the sample for this study. Etikan et al. (2016) described purposive sampling as 
one of the cardinal features of descriptive qualitative studies and as the recommended 
sampling technique for descriptive qualitative design. The goal of purposive sampling is to 
include participants who are rich in information for the purpose of the study (Sandelowski 
2000; Lambert and Lambert 2012). 
 
3.5 DATA GATHERING  
Data gathering is about processes and instruments used to gather information from the 
participants for a study (Polit and Beck 2014). After obtaining ethical clearance from the 
university (No: M170469) (Annexure C) and permission from the hospital to conduct the 
study (Annexure D), the researcher recruited the participants. The patients’ files were 
reviewed at the head and neck cancer clinic to identify eligible participants based on the 
inclusion criteria and patients who met the inclusion criteria and waited for transport provided 
by Cancer Association of South Africa after their scheduled doctors’ review, were 
approached and invited to participate in the study. Participation was voluntary. Nineteen 
patients were approached; one patient was not comfortable with the recording of the 
interview and refused participation. An information sheet (Annexure A) was handed to those 
who were willing to participate and the study was explained to them, thereafter informed 
consent was obtained. Eighteen patients were included in the study (n=18).  
 
Once informed consent was obtained, general information was gathered (Annexure F) 
followed by unstructured interviews. Unstructured interviews are interviews in which 
questions are not prearranged and is the suitable method of data gathering in a study 
whereby little is known about the subject under study (Doody and Noonan 2013), as was the 
case in this study. One opening question was posed: Please tell me what is it like for you to 
live with cancer of the head and neck (Annexure G). Probes and prompting questions 
followed, based on the participant’s answer, in order to clarify issues and enhance an in-
depth description of the participant’s experiences (Polit and Beck 2014). The first interview 
pre-tested the question. Hurst et al. (2015) defined pre-test interview as an interview 
designed to determine if the question is clear to the respondents and their understanding of 
the question. The purpose of pre-test interviews is to refine the question with regard to the 
length of interviews, language clarity and cultural acceptability of language used (Doody and 
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Noonan 2013). The participant understood the question well and no changes were made to 
the question. The data gathered during this interview was included in the analysis.  
 
The interviews were conducted in a private room to ensure comfortability, privacy and 
confidentiality (Health Profession Council of South Africa 2015), allowing the participants to 
feel free to give honest information regarding their experiences. The interviews were 
recorded using a digital voice recorder, which is one of the recommended tools for capturing 
information from informants during interviews (Doody and Noonan 2013).  
 
The researcher, a male registered nurse and a Master’s student in the field of Oncology and 
Palliative Care nursing, was practicing in the Oncology Unit before and during the data 
gathering. The data were gathered by the researcher between 1st November 2017 and 21 
December 2017 and the interviews lasted on average 45 minutes.  
 
3.6 DATA ANALYSIS 
Data analysis is the process of creating meanings from data, and in qualitative research it 
involves building themes from ideas and making conclusions about the themes (Bazeley and 
Jackson 2013). Qualitative content analyses, the preferred method of analysing descriptive 
qualitative data (Sandelowski 2000; Vaismoradi et al. 2013) was used to analyse the data. 
An inductive approach was used due to the lack of knowledge about the topic (Elo and 
Kyngäs 2008). The data were analysed following the six steps as described by Smith and 
Firth (2011).  
Step 1: Verbatim transcription 
Transcription began by listening to the recorded information repeatedly. The voice recorder 
was paused to allow for transcribing the information word for word, as it was heard. After the 
transcription, the process was repeated in order to capture any possible missing information 
during the initial process. Each transcript was identified by the same number as the one 
assigned to the recorded information for easy identification.   
Step 2: Understanding the data  
The transcripts were read and re-read until the data were clear to the researcher before an 
attempt to identify main ideas was made to gain familiarity with the data (Jolley 2013). 
Transcripts needing clarity were given clarity by listening to the corresponding recorded 
information again and re-reading the transcript, whereafter changes were made on the 
transcript where necessary to make complete sense of ideas. 
Step 3: Identifying the main idea 
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The main ideas were noted by using highlighters of different colours, while headings and 
notes were written in the margins of the transcript. This process of reading and identifying 
ideas was done repeatedly to ensure that no headings describing all aspects of the content 
were missed.  
Step 4: Grouping the ideas into sub themes 
Headings and ideas from the different transcripts were recorded on separate sheets of 
paper. The ideas were carefully studied to identify relationships among them and those that 
fell under the same category were grouped to form a sub-theme. The list of ideas was read 
repeatedly to make sure the ideas were grouped into meaningful sub-themes and to ensure 
no ideas were misplaced. 
Step 5: Building main themes  
The sub-themes were critically examined to identify those that were communicating the same 
sense and similar sub-themes were combined to form main themes. Unrelated sub-themes 
were carefully re-examined to look for a possible relationship among them so that they could 
be grouped into one group and represented by one theme. The process was revisited 
repeatedly until all the sub-themes were built into main categories.  
Step 6: Identifying main themes 
The grouped sub-themes and supporting ideas were scrutinised carefully to identify higher 
order headings that fit each category of the sub-themes. Each category was then 
represented by higher order headings as the main theme. 
The researcher analysed the data with the assistance of the supervisors. The researcher 
used reflexivity to ensure the results of the study were not affected by his personal beliefs 
and pre-conception. Reflexivity is the process of understanding oneself as a researcher in 
relation to the study, in that beliefs, preconceptions and assumptions of the researcher are 
examined in relation to the study (Haynes 2012). According to Palaganas et al. (2017), 
reflexivity involves paying systematic attention to the details of knowledge construction at 
each stage of the research process.  
 
3.7 TRUSTWORTHINESS 
Trustworthiness refers to the exposition of the true value of the research results and the 
strong relationship between the data and the conclusions made (Elo et al. 2014). In order to 
enhance trustworthiness in this study, Guba’s constructs of ensuring trustworthiness, 
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credibility, transferability, dependability and confirmability were used (Shenton 2004; Thomas 
and Magilvy 2011). 
3.7.1 Credibility  
Burns and Grove (2010) described credibility as the correctness or accuracy of the research 
findings in the eyes of other experts in research. In order to address credibility, the research 
methods used in this study were adopted from previous methods, which had been used 
successfully in previous studies with similar research questions. The sample for this study 
composed of participants from different racial and cultural backgrounds and age groups to 
ensure triangulation of data sources. Polit and Beck (2014) defined data source triangulation 
as using data gathered from multiple sources based on space, person and time. Person 
triangulation which involves gathering data from different types of people for the purpose of  
ensuring credible data through multiple perspectives as guided by Shenton (2004) was used 
in the current study as described above.  
The proposal of this study was peer reviewed. Frequent discussion sessions between the 
researcher and the supervisor, who is an expert in research, were conducted throughout the 
study to review the progress of the study and for advice.    
The participants were purposefully selected based on specific inclusion criteria and 
participation was voluntary, allowing the gathering of true data from participants who were 
genuinely willing to share their story. Probes and follow up questions were asked after the 
open-ended question in order to gather comprehensive data. To ensure familiarisation with 
the research setting, the researcher practiced at the research setting for more than three 
months prior to the data gathering process. Data gathering proceeded until saturation was 
reached so that important data regarding the research question were gathered. During the 
interviews, a summary of the information obtained was repeated and the participants were 
asked whether this was a true reflection of their story so that only the participants’ views of 
the experiences were gathered. 
3.7.2 Transferability  
According to Polit and Beck (2012), transferability is the extent to which the research results 
can still hold true in other settings or contexts. In the current study, the research setting, 
research methods and the participants’ characteristics were described in detail, which allows 
the readers to judge the conclusions and make a decision as to whether or not to use the 
results in their setting (Thomas and Magilvy 2011). 
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3.7.3 Dependability  
Dependability refers to the consistency and repeatability of the research findings under the 
same conditions (Jolley 2013). To enhance dependability, a full description of the research 
method, and how the conclusions were reached, were included in this research report so that 
interested parties could easily follow the source of the conclusions. The same open-ended 
question was asked to all participants, to ensure consistency, and probes and follow up 
questions were asked depending on the participants’ answers to ensure rich data were 
gathered.  
3.7.4 Confirmability  
Confirmability is the evidence that the research findings are the true reflection of the data 
gathered (Thomas and Magilvy 2011). An audit trail was developed through a full description 
of the study’s steps to allow other researchers to judge the conclusions made from the 
research data.  
 
3.8 ETHICAL CONSIDERATIONS 
Research ethics refers to considerations that the researcher undertakes to ensure protection 
of human participants from harm, respect for their rights and maintenance of their personal 
privacy and confidentiality. In order for this study to be conducted in an ethical manner, the 
researcher followed the Health Professions Council of South Africa’s general ethical 
guidelines (Health Profession Council of South Africa 2015), which include ethical values, 
standards and principles. 
3.8.1 Procedural ethics 
In order to ensure formality of this study, the research proposal was presented to the 
Department of Nursing Education for peer review to assist with clarification of ethical issues. 
The proposal was also approved by the University of Witwatersrand Postgraduate 
Committee, the Human Research Ethics Committee and the authorities at the research site. 
Data in the form of written records are kept in a double locked cabinet and data in soft copy 
are kept in a password protected hard drive to prevent unauthorised access to participants’ 
information. Data is to be kept for a minimum of two years after publication of an article and 
no data will be taken out of South Africa (Britz and le Roux-Kemp 2012). 
3.8.2 The research field ethics 
The principle of respect for persons demands respect for participants’ autonomy and 
confidentiality throughout the study. The information regarding the purpose of the study, risks 
and benefits of the study and the procedure of data gathering were given to the participants 
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in order for them to make informed decisions about participation. The participants were 
informed that they were free to ask questions, which would be answered, regarding 
participation in the study.  
Written informed consent for participation and for recording data by means of a voice 
recorder was obtained from the participants (Annexures B and D). The participants were 
informed of their freedom to withdraw their participation at any time without any punishment 
or denial of their privileges as patients and no participant was coerced to take part in the 
study. Anonymity of the participants was observed by assigning pseudonyms to the 
participants, which were used throughout data gathering and reporting. Data are kept in 
password protected hard drive and the transcripts are kept in double locked cabinet to 
prevent unauthorised access The principle of best interest demands the protection of 
research participants from harm and the researcher must act in a way that promotes good for 
the participants. No physical harm was anticipated, however sharing of experiences could 
have led to emotional distress therefore, arrangements were made with a specialist mental 
health nurse to counsel patients if the participant wanted to referred at any point during or at 
the end of the interviews. Five participants broke into tears during interviews and the 
researcher allowed them time to expend their emotion and later asked if they wanted to be 
referred to someone and if it was okay to continue with the interviews. However, none of the 
affected participants wanted to be referred for counselling and allowed the interviews to 
continue to the end. At the end of the interview, the affected participants were asked if they 
wanted to be counselled and all of them responded that it was not serious and they did not 
want to be referred for counselling.    
The principle of justice in research demands fair treatment of participants during the study 
period and equal benefits and burden of the research. Justice was achieved through 
selection of participants based on the inclusion criteria which did not segregate patients 
based on their social status or vulnerability. Patients who declined to participate or withdrew 
their participation were treated the same way as those who participated without segregation 
or prejudice. It was anticipated that the findings would help health practitioners to have an 
insight of the experiences of patients with head and neck cancer, which would enable them 
to provide evidence-based care to all patients suffering from the disease.  
3.9 SUMMARY 
In summary, Chapter 3 presented the research design and methods, which included the 
population and sampling, data gathering, data analysis, trustworthiness and ethical 
considerations. Chapter 4 will present the research findings and discussion. 
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CHAPTER 4: 
RESULTS AND DISCUSSION 
 
4.1 INTRODUCTION  
Chapter 3 presented the study design and methods, measures to ensure trustworthiness and 
the ethical considerations. This chapter will be centred on the findings of the study and the 
discussion. The findings will include participant characteristics, a description of major 
themes, the discussion and a summary. 
 
4.2 THE PARTICIPANTS  
Eighteen people (n=18), of which more than half were males (14 of 18), consented to take 
part in the study. The participants were from four major population groups, with the majority 
from the black population (13 of 18). Their ages ranged from 26 to 73, with an average age 
of 50.8 and a standard deviation of ± 13.6 years; the median age was 51.8 and the modal 
age classes were (40-49) and (50-59). The largest number of participants were married and 
unemployed (10 of 18); half had an income of less than the breadline indication of R779 
(Business Report 2015). More than half of the participants had at least attended high school 
(11 of 18). Some participants had gastric tubes for feeding (3 of 18), while others had 
tracheostomies (2 of 18), and their duration of sickness ranged from 3 months to 72 months 
with an average of 18 months; most (11 of 18) had lived with cancer of the head and neck for 
24 months. Half of the participants were treated with radiotherapy and chemotherapy, while 
the rest were treated with other treatment modalities such as surgery alone, radiotherapy 
alone, chemotherapy alone or combination of the three (Table 4.1). Some participants were 
still on treatment (8 of 18) while the rest completed the treatment (10 of 18). 
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Table 4.1 Participants’ demographic data  
Pseudo 
name  
Age  Gender  Level of 
education 
Marital 
status 
Diagnosis Treatment Monthly 
income 
level versus 
breadline 
Alex  72 Male  Grade 12 Married  Ca oral cavity Radiotherapy Above  
Allan  55 Male  Grade 8 Single  Ca oral cavity Radiotherapy  Below  
Anna  63 Female Grade 8 Married  Ca palate and 
sinus 
Chemotherapy  
Radiotherapy 
Below  
Arimedin  68 Male  Grade 4 Married  Ca larynx  Chemotherapy  
Radiotherapy 
Above  
Austin  68 Male  Grade 8 Married  Ca soft palate Chemotherapy  
Radiotherapy 
Above  
Ben 54 Male  Grade 9 Single  Ca oropharynx Chemotherapy 
Radiotherapy 
Below 
Dan 43 Male  Grade 12 Married  Ca nasopharynx Chemotherapy  
Radiotherapy 
Below  
Esther   35 Female  Grade 10 Married  Ca buccal  Surgery Above 
Evans  28 Male  Grade 4 Married  Ca oral cavity Surgery 
Radiotherapy 
Below  
Jack  61 Male  Grade 12 Married Ca nasopharynx Radiotherapy 
Chemotherapy 
Above  
James 29 Male  Grade 12 Single  Ca nasopharynx Chemotherapy  
Radiotherapy 
Above  
Leah  54 Female  Grade 11 Married  Ca nasopharynx Chemotherapy  
Radiotherapy 
Below  
Liam  42 Male Grade 8 widower Ca oral cavity Radiotherapy  Below  
Max 43 Male  Grade 12 Married  Ca larynx Surgery 
Chemotherapy   
Radiotherapy 
Above  
Mc duff   59 Male  Grade 12 single Ca tongue Chemotherapy  
Radiotherapy 
Above 
Mercy 26 Female  Grade 10 Single  Ca oral cavity  Chemotherapy 
Surgery   
Radiotherapy 
Below  
Norman  43 Male  Grade 12 Single  Ca nasopharynx Surgery  
Radiotherapy 
Below  
Xolan 56 Male  Grade 7 Married  Ca tongue Radiotherapy  Above  
* Above the breadline = more that R799 per month (Business Report 2015) 
 
4.3 THEMES ARISING FROM DATA  
Two themes and five subthemes arose from the data and are summarised in Table 4.2 
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Table 4.2 Themes and subthemes arising from the data  
Theme Subtheme 
Living with the consequences of the 
disease and treatment.  
Emotional effects of the head and neck 
cancer. 
Physical consequences of the disease and 
treatment. 
Socioeconomic implications.  
Coping with a changed life. The importance of psychosocial support. 
 The importance of hope and spirituality. 
 
4.3.1 Living with the consequences of the disease and treatment “My life has 
undergone a horrible twist…” 
Subtheme 1: The emotional effects of the head and neck cancer 
Most of the participants agreed that learning their diagnosis was a shocking experience, 
which led to negative emotional responses such as fear, uncertainty, isolation and even 
thoughts of suicide. Allan explained, “When I was told that I have this disease, ijoh! it was 
painful my brother. I was thinking to make a suicide…I was always alone thinking of this thing 
and I was isolating myself from the family but now I am okay.”  James added, “To me, I was 
surprised because no one at home has got cancer or anything related to it, I am the first 
person at home… so eeeh! … so everyone is busy asking me if no one had cancer before 
whether I took it from them or what but there is no one at home, I was the first one to have 
cancer so I was surprised…” 
Experiencing the distressing symptoms of the disease and not knowing the cause, made 
learning about the diagnosis easier for some participants and gave them hope. Ester 
explained, “They told me that it was buccal cancer… I just appreciated it because there are 
some other diseases that are worse than this…Umm, I just took it like you know, if they see 
it, I was happy because before, for this sickness, I didn’t know what was happening with me, 
so I was happy about that. So far I am happy because I know that what is happening inside 
is cancer and I am happy because I know that if something is seen and the doctor know that 
it is cancer then it can be treated and so on and so on.” In addition, having previously 
suffered from cancer also made learning the diagnoses easier. Anna said, “… the result 
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came out and they said that it was cancer of the sinus. But after that, aahmm… you go on 
living, you understand what I mean, because when I had breast cancer it was a shock 
because I was told that when you got cancer then you are going to die but after that I am still 
alive up to five years after treatment now and then I got this sinus cancer...”  
Living with the disease was not easy. The lives participants knew before they became ill 
changed and they experienced their lives as a “living hell,” “difficult,” and “something is lost.” 
Alex said, “It’s very painful…Sometimes it makes me very low, down, and you think, why 
does it happen to me because I was a person that was very health, I had no troubles and 
now all over sudden why all this…”  Dan agreed and said, “It is painful, my life is no longer 
the same….it is difficult to live with this cancer because every time when you are happy you 
get pain so difficult to live with it. It is affecting me more because enjoy my life the way I used 
to do… life is like a living hell and I feel like I have lost everything.” Arimedin added, 
“[sobbing] You know, you can’t feel good, you can’t feel good because you can’t do things 
that you used to do, you know, it is so worrisome.” However, participants were also 
pragmatic about their illness and experienced it as merely another illness and part of life. 
Esther said, “Aah, you just get used on it and you just tell yourself that it is part of life… there 
is no any other thing you can do, it’s just part of life, it’s another sickness that you can be 
with.”  
Receiving treatment did not console all the participants, some felt uncertain about the 
treatment, and if it would result in a positive outcome. They also feared disease recurrence 
despite the fact they received treatment. Even the slightest discomfort in their head and neck 
region created fear that the disease had recurred. Alex explained, “Yeah I was very much 
concerned, I was very much worried… there was always at the back of my mind, whether I 
am gonna make it or I am not gonna make it…whether this treatment is gonna be successful 
thus what makes me worried.”  Austin said, “It makes you worried, it does make you worried. 
When you get a little pain in the throat during radiation, you think it is coming back but it does 
a bit does affect the mind…”  Norman added, “So it affects you, you see, because there is 
this thing what they call it recurrence after the treatment… even if when you ask the doctors, 
there is no guarantee that the disease won’t come back, you see... So cancer affects you, 
knowing that even cancer has been treated but it is very much possible that it can come back 
that is one thing really that affects, hmm I mean one’s psychological.” 
Subtheme 2: The physical consequences of the disease and treatment 
The participants agreed the cancer and its treatment resulted in severe suffering. Chronic 
pain was one of the most distressing symptoms the participants experienced.  Esther said, 
“Well, like when this thing started, it was just like a small pimple then… when I opened my 
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mouth I just saw there was very reddish veins… the thing was very painful like fire, I couldn’t 
even sleep on my left cheek and I used to sleep on my right hand only…” Allan said, “Hmm 
it’s painful, you can’t stand it… every time you must drink tablets in order to be free from 
pain.” James agreed saying, “… for me it was only this disease like I was feeling pain like 
daily, the whole day so like I was drinking pills almost like every time...”  
Participants who received radiotherapy developed mucositis, which was responsible for 
severe pain in the mouth and throat. The participants described it as having a “sore mouth,” 
“ulcers” and “swelling tongue.” Pain in the mouth and throat resulted in severe eating 
problems such as dysphagia, anorexia and difficulty with chewing.  Alex said, “…it’s very 
painful… I can’t eat properly and I have completely lost my appetite… I eat only soft food, I 
can’t drink coffee as I used to...” Dan also added, “It is painful… during the treatment I was 
sick, I could not eat properly…I had mouth sores and they were very painful…Yes, my food 
is always soft… I mustn’t drink cold drinks and all food that contain acids I don’t eat it…it was 
difficult to eat anything.”  
The participants experienced other complications because of the radiotherapy, such as 
xerostomia and trismus. Jack explained, “I think my saliva is becoming thicker and I don’t 
know if I will be able to cough as treatment goes on…” Ben added, “…though physically I am 
not hundred percent as before. I am still encountering minor problems such as dry mouth, 
heartburn, cramps, stiffness of the neck, you know, uncomfortable. These are things that I 
encountered after I had undergone this kind of treatment.” Anna said, “I took my radiation; 
after treatment I am not on any medication because I don’t have any pain…. it’s just that I 
can’t open my mouth here and there…”  
Eating was a major problem for the participants and having to remove their teeth prior to 
radiotherapy caused emotional distress. Not only did the absence of teeth affected chewing, 
they were also not able to eat some foods. Evans said, “… so I can’t eat properly…I am 
affected because I am not eating nicely…all my teeth are removed before treatment because 
the doctor said so and there is a hole in the roof of my mouth… hmmm, because of the 
disease and radiation.” McDuff added, “They also removed all my teeth because of 
radiation… and I don’t know whether they are going to put false teeth for me or not.”   
Some participants had to live with feeding tubes, which added to their suffering. Participants 
described living with a tube as “eating without satisfaction,” “selective eating” and “admiring 
nice food that I cannot eat.” Evans said, “…I eat with the tube…I am affected because I am 
not eating nicely, yeah my stomach is not full…It affects me… it affects me because my 
stomach does not get full…. Sometimes this tube can block and I cannot feed properly. 
Hhmm I don’t eat any food like I used to do before the sickness...” Liam added, “I can’t do 
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nothing in the mouth and the doctor put the tube for me to eat…You see, what food I am 
eating, only liquid. This bread I want to crush it, crush it, it must be liquid. I am taking meal 
like this in morning, lunch and in evening.” 
Not being able to eat caused persistent fatigue expressed as “weakness” and “tiredness.” In 
addition, participants experienced severe weight loss described as “I have remained with 
bones only,” “I am not strong as I was” and “all my flesh is gone.” Severe weakness and 
weight loss had negative influence on participants’ emotions and added to their emotional 
distress.  Alex described his experiences, “Well, it’s very painful, the thing is that I am losing 
weight, I can’t eat properly…” Jack added, “I feel pain in my heart…I feel troubled because I 
have lost weight, I am not strong anymore because I don’t eat enough. I admire when I see 
others eating well but there is nothing I can do…You know, I used weigh more than 80 kilos 
but now I am weighing less than 65 and all my good looking self is gone because my flesh is 
gone and I have remained with bones only as you can see. All this is because I am not 
eating enough…” 
The physical consequences of the disease and treatment also caused severe communication 
problems for the participants. Some of the participants could not pronounce certain words, 
some lost their voices and some lost their speech completely. Evans explained, “You know 
my voice cannot come out nicely, I can’t say some words nicely and other peoples cannot 
hear what I speak. I have to repeat many time before someone can hear me…hmmm when I 
am with my friends I cannot chat properly because they cannot hear me and hmmm there is 
nothing I do to help it...” 
The facial disfigurement some participants experienced had severe negative consequences 
on participants’ body image. Some participants covered the disfigured part with a mask or 
cloths and some wished they could just die. Mercy said, “Mmm sometimes, when I finished 
the operation, I wish I could die… this thing is in my face and people look at me, some judge 
me calling me that I am HIV, you see it is not easy…”  Max explained, “…so the whole area 
of radiation is now hard like a rock, it will never come right, the doctor said it will never come 
right…because my operation my eye is not on the straight position and my mouth in skewed 
to one side like this…you see my mouth is going this way… and then also it’s nerve and all 
those stuff were cut off in order to take off this thing.”  Dan added, “…they took it away, my 
nose, because of the disease and you see I have been putting on the mask, just to cover 
up… shame, so that other people should not see what has happened to my face.” 
Subtheme 3: The socioeconomic implications of the disease and treatment 
The emotional and physical implications of head and neck cancer had a negative influence 
on the participants’ relationship with other people. The participants were stigmatised, 
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rejected by their friends out of fear of being infected with cancer and even mocked because 
they were unable to speak clearly. James said, “…at the start they were surprised, but like 
there is one thing that keeps making me laugh because my friends are telling me that I could 
give them because this cancer can be passed on from one person to the other. So they think 
that they could get it from me, yeah, thus the only thing they talk about.” Dan added, “Hmmm 
when I am with my friends I cannot chat properly because they cannot hear me and hmmm 
there is nothing I do to help it…They tell me that I just have to keep quiet because they can’t 
hear me and some them feel bad it and some do understand my problems. But it is difficult 
live among friends with this problem…Sometimes I just walk away because I feel that it is all 
my fault, sometimes I just stay with them while feeling bad just to keep company with them...”   
The weakness, pain and facial disfigurement the participants experienced led to relationship 
problems. They agreed that pain and persistent fatigue negatively affected their ability to 
indulge in sexual activities with their partners. Jack said, “First of all, I no longer have sex 
with my wife because of the pains I feel…but it difficult to have sex with my wife because of 
the pains I feel most of the times. Sometimes I feel very weak that cannot do sex with my 
wife…I don’t have power to have sex with my wife anymore. I cannot think of sex with my 
wife because of the pains I feel most of the times.” Some participants even lost their life 
partners because of their facial disfigurements and their partners’ lack of understanding of 
the disease. Mercy said, “…I am not married but I was in relationship and it ended because 
this sickness. I think I was not looking good to him anymore and he decided to leave me for 
other women.” James added, “Eeh that girlfriend, actually thus the problem now, the 
girlfriend because like since I got sick everything has changed, to me it is like she is cheating 
on me, the way I see it because she doesn’t understand anything about cancer…so to her it 
like from now on I am just wasting her time so I broke up with her because she doesn’t 
understand my situation…”  
The participants agreed that the persistent fatigue, weakness, pain and social stigma they 
experienced rendered them unable to work, which resulted in serious financial difficulties. In 
addition, participants said that despite having had treatment and recovering to the extent 
they could resume work, they were regarded as still sick and not fit to work by other people. 
Xolan said, “…I cannot do anything because I am weak ne … like I can’t go to work, bathing 
myself at home…The problem is that I used to work and bring salary home but now I cannot 
all that and now it’s my wife alone, so her salary cannot take care all of us.” Norman 
explained, “You see, the stigma of this disease cancer… even now I myself I feel strong now 
but they are still regarding me as someone who is sick. They say hey you mustn’t do this, 
you know you got cancer and I don’t feel okay with that.” The participants also agreed that 
travelling to the hospital and the special food they needed added to their financial burden. 
Jack said, “…ehh… now my family is suffering and my relatives because now they have to 
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see that I have a money to come to the hospital, they have to see that may be pap or rice 
doesn’t taste well in my mouth, so they make sure that they buy something that I can eat 
well...” 
Being diagnosed with cancer of the head and neck was a shock. It created fear, uncertainty 
isolation and even thoughts of suicide. For some participants, experiencing the distressing 
symptoms of the disease and not knowing the cause made learning the diagnosis easier and 
gave hope. The lives participants knew before they became ill changed and they 
experienced their lives as a living hell. Receiving treatment did not console all the 
participants, as some felt uncertain about the treatment and whether or not it would result in 
a positive outcome; some feared that the disease would return. The distressing symptoms of 
the disease and treatment, such as pain and mucositis, and the complications, such as 
xerostomia and trismus, resulted in eating becoming a major problem. Not being able to eat 
caused persistent fatigue and severe weight loss, which had a negative impact on 
relationships and work. In addition, the facial disfigurement and the communication problems 
the participants experienced also had a negative influence on social interactions and 
financial activities, which caused serious financial problems.   
4.3.2 Theme 2: Coping with a changed life: “You have to learn to live with it” 
Subtheme 1: The importance of psychosocial support 
Having supportive family, friends and relatives helped the participants cope with the negative 
consequences of the disease and treatment. The participants agreed their family members 
were there for them, to encourage them and provide material and financial support. They 
believed that without family, life would be even more difficult. Dan said, “I have got all the 
support…any support, finance, treatment, yeah, when I am asking for something they give 
me and they also encourage me…I feel good, I feel relieved and I feel like I am in safe 
hands. Without my family, I don’t know what I would do and I think things could have been 
difficult without them.” Max added, “…and my wife works in the hospital…so you see she has 
a lot of knowledge about this stuff because they see a lot of cancer patients. And my cancer 
in comparison with those people is nothing because some had very bad cancer…my wife is 
my source of hope…”  
Being accepted and supported by friends also assisted the participants in coping with their 
challenges. The encouragement of friends and being able to be with them was very 
important and brought hope. Ben said, “Oh well, friends have been coming like to give me, 
you know, like support, you know, spiritual support to say okay, get well soon. They are 
happy that I am still alive because you know cancer is a very severe disease but fortunately, 
you have managed to overcome it by being consistent with your treatment.” Not having 
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support and friendship from relatives and friends added to the burden of the participants. 
Liam said, “I am alone…everything that was happening I was just doing myself, no one was 
coming to help about me…it was hard my friend, but I did because there was no choice I 
have to do it. No one came and help me; I was myself to doing everything…”  
Participants agreed that sharing information and experiences with other patients who also 
has cancer decreased their emotional distress and gave them hope. James explained, “The 
most fear I had was that I thought it is gonna kill me same time, you see, I was gonna die 
that was the most thing that was scaring me but when I was always talking to people about 
me and stuff, they told me, no, this disease is curable, radiation could help you a lot. So thus, 
when I started to believe that you know was there cure or solution for me to get better for 
cancer. So I wasn’t scared to that extent…Most the people I was talking with about this 
cancer were patients…and I got more information from them...As of now there is a lot of 
hope.” The doctors who treated the patients also gave them hope by giving them information 
and advice. Leah said, “The doctors told me that if you see this on, let’s say pain, don’t worry 
about this, just focus on treatment… so I followed the things that doctor told me…When I 
came back to the doctor to complain that I can’t eat and I can’t swallow, they gave me things 
to wash my mouth and they told me that it is gonna be fine but it is going to take long…Yeah 
it helped me a lot…the doctors gave me hope.” 
Receiving a social grant relieved the financial pressure some of the participants experienced. 
Receiving the grant helped them to buy food and other basic commodities during the time 
that they could not work However, the grant was not sufficient to meet all the needs of the 
participants and their families. Xolan said, “Yeah, It’s only the money from SASSA that come 
to our rescue us, yeah, trying to feed my children, anything.” However, some participants still 
had financial difficulties regardless of the government grant and they said the grant was not 
enough to meet their financial needs. Jack added, “…I applied for the government grant and 
they gave me and it is the one that is assisting me up to now…before this cancer, it was 
enough to help me and my family but now it is not enough to help with issues of transport to 
the hospital, pay for treatment and also to help at home…”  
Subtheme 2: The importance of hope and spirituality 
The participants agreed that having hope, being positive and having faith in God and prayer 
support helped them to cope with their cancer journey. Hope was a key factor that helped 
them to cope emotionally. Ben said, “Oh well, I didn’t feel that bad knowing that one day I am 
going to recovered fully, I will be okay and physically, I will regain weight, facially I will be 
okay again…” Alex said, “…the thing is I have to stay positive, I have to stay focused and I 
have to think that this medical treatment is gonna help me.”  
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Having trust and faith in God also facilitated coping. The participants believed God was in 
control of their situation and trusted God to heal them. Anna said, “God is the one who does 
the healing with the help of doctors…I believe and trust the Lord to be caring through just 
difficult times.” Alex added, “I read my bible and sometime I play some music and yeah it 
helps a lot, it soothes me…the holy spirit helps you a lot, it comforts you.”   
Some participants were of the opinion that God gave them a second chance by means of 
their cancer diagnosis. Dan said, “Eeh God helped me a lot yeah, I often pray while I am still 
living…previously my relationship with God was too small, I did not have time to pray 
because I was a criminal, let me tell you straight, yeah, so now since I became sick I am 
working with God…My life changed after the sickness.”  Ben added, “I feel so loved and I 
mean to be given another chance in life is so exciting…God just gave me another chance for 
me to do my work and I am thanking him for that.”  In contrast, some participants doubted the 
existence of God because they felt their prayers were not answered. Mercy said, “Sometimes 
I feel God is not there because you pray asking for things and not happening…”  
Having a supportive family, friends and relatives helped the participants cope with the 
negative consequences of the disease and treatment. Being accepted and supported by 
friends also assisted the participants to cope with their challenges. Participants agreed that 
sharing information and experiences with other patients who also have cancer, decreased 
their emotional distress and gave them hope. Receiving a social grant relieved the financial 
pressure some of the participants experienced. In addition, participants agreed that having 
hope, being positive and having faith in God and prayer support helped them cope with their 
cancer journey. Some participants were of the opinion that God gave them a second chance 
by means of their cancer diagnosis however others doubted the existence of God because 
they felt their prayers were not answered. 
 
4.4 DISCUSSION  
This study provided evidence that being diagnosed with cancer of the head and neck was a 
shock and created fear, isolation and even thoughts of suicide.  Experiencing these emotions 
is not new among these patients. Jagannathan and Juvva (2016), in a study related to 
emotions and coping among head and neck cancer patients, found shock and fear as the 
most distressing emotional reactions experienced. The evidence shows that patients 
experience these emotions when they are not sufficiently prepared prior to the disclosure of 
the diagnosis and also when they lack emotional support after the diagnosis (Singer et al. 
2012). Whether the participants in the current study received emotional support after learning 
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the diagnosis is not clear. However, for those who found answers to the distressing 
symptoms they experienced, made learning the diagnosis easier.  
Similar to people living with other types of cancer, the participants feared the treatment they 
received would not be successful and their disease would return. Kanatas et al. (2015), in a 
study conducted in the United Kingdom, found fear and uncertainty are important emotional 
problems for the patients living with head and neck cancer. In addition, Hulbert-Williams et al. 
(2014) said that fear of recurrence is the most distressing psychological problem for patients 
with aero digestive tumours and it persists even after treatment. Fear of recurrence affects 
the patients’ psychological health and relates to poor quality of life among head and neck 
cancer survivors. In a study about the relationship between fear of recurrence and quality of 
life conducted in United States of America, Van Liew et al. (2014) found that more than 60% 
of the head and neck cancer patients experienced fear of recurrence and poor quality of life. 
Similar findings were reflected in a systemic review of literature, conducted in Ireland by 
Dunne et al. (2017), which described the relationship between psychological factors and 
quality of life. 
Living with cancer of the head and neck was not easy. The lives participants knew before 
they became ill changed and they experienced their lives as a living hell. The distressing 
effects of the disease and treatment, such as pain, mucositis, xerostomia and trismus, added 
to their suffering and made eating a major problem. Unfortunately, these distressing 
symptoms and complications are common for patients living with this type of cancer. 
Molassiotis and Rogers (2012) support this finding by means of a qualitative study done in 
the UK, on experiencing the symptoms of head and neck cancer and treatment, and found 
the oral symptoms these patients experienced made eating a major problem. In a study to 
describe the eating experiences of these patients conducted in Sweden,  Ottosson et al. 
(2013) reported that eating problems persist even after treatment of the disease. In addition, 
feeding tubes as a temporary or permanent intervention also have negative effects on eating. 
The current study has provided evidence that participants experienced feeding tubes as 
eating without satisfaction, selective eating and undesirable. In support of these findings, in a 
literature review on eating-related consequences of the disease and treatment, Ganzer et al. 
(2015), found lack of satisfaction and limited feeding as important problems associated with 
feeding tubes and which caused poor quality of life for patients with head and neck cancer. 
Not being able to eat caused severe weight loss and added to the persistent fatigue the 
participants experienced. Some participants were unable to work, whilst others lost their paid 
employment. Larsson et al. (2005) support these finding and state that being unable to eat 
causes severe weight loss for head and neck cancer patients. With regard to the fatigue, 
Nautiyal et al. (2015) found the fatigue that patients diagnosed with head and neck cancer 
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experience, starts before radiotherapy and persists afterwards. It is well known that the 
persistent fatigue these patients experience negatively influences their daily activities and 
work life.  In the current study, persistent fatigue rendered the participants unable to work, 
which resulted in serious financial problems. In support of these findings, Nautiyal et al. 
(2015) reported a strong negative association between persistent fatigue and work life of 
patients living with the head and neck cancer, resulting in serious financial consequences.  
As with any other cancer, fatigue causes sexual problems. In a literature review focusing on 
the effects of fatigue on sexuality of the patients living with cancer of the head and neck, 
Rhoten (2016) reported fatigue as a significant cause of sexual problems among these 
patients. In confirmation of the aforementioned, the current study has provided evidence that 
fatigue resulted in participants’ sexuality problems, to the extent that they failed to indulge in 
sexual activities with their partners.   
Some of the participants experienced facial disfigurements, which had a negative effect on 
their self-image. Nayak et al. (2015), in a systematic review of the literature focusing on the 
relationship between facial disfigurement and self-image in head and neck cancer patients, 
found facial disfigurements caused negative changes in self-image. In response to disfigured 
faces, some participants in the current study covered their faces with masks or cloths and 
some felt a negative change in their appearance, which Henry et al. (2014) described as 
disrupted self-image. 
The facial disfigurement problems resulted in the participants being stigmatised and rejected 
by their friends. According Threader and McCormack (2016), facial disfigurements are a 
major causing factor for social stigma and rejection experienced by patients living with 
cancer of the head and neck. In a study conducted in Canada on the consequences of social 
stigma on the patients’ psychosocial life, Lebel et al. (2013) found the stigma and rejection 
experienced by these patients had devastating consequences on their psychosocial lives and 
negatively affected quality of life. In agreement to the above evidence, in the current study, 
participants mentioned similar stigma-related psychosocial problems and some participants 
were even ridiculed by their friends.  
In addition, the communication problems participants experienced made social interactions 
difficult. Unfortunately, these communication problems, such as impaired speech and voice, 
are well known issues of concern for patients with the head and neck cancer. In a study 
conducted in the Netherlands, on the communication problems associated with head and 
neck cancer and treatment, Jacobi et al. (2010) found speech and voice impairments as 
major problems experienced by these patients. The current study found some participants 
experienced rejection and humiliation due to the inability to communicate with their friends 
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and they felt unwanted by their friends. In line with these findings,  Kraaijenga et al. (2016) 
found that the communication problems these patients experience have a devastating effect 
on their daily interaction with their friends and it negatively affected the patients 
psychologically. Similarly, the above findings were reflected in an Australian study focusing 
on communication changes and their influence on a patients’ life (Nund et al. 2015).  
The current study also provided evidence that living with tracheostomies made patients’ lives 
difficult. A study conducted in Korea on tracheostomy related morbidities, revealed that head 
and neck cancer patients with tracheostomies experienced bleeding, leaking and blockage of 
the tracheostomy, which was distressing to them and their guardians (Lee et al. 2016). As 
confirmation to the findings reported in Korean study, the participants in the current study 
also mentioned similar problems associated with tracheostomy and added that their voice 
and speech were impaired due to this intervention. Two studies conducted in the United 
Kingdom on tracheostomy experiences of the head and neck cancer patients, also reported 
physical problems, such as impaired voice and speech, chocking and discomfort, which 
caused fear for the patients (Coyle et al. 2017; Rogers et al. 2017). 
Having supportive families, friends and relatives helped the participants to cope with the 
negative consequences of the disease and treatment. In addition, being accepted and 
supported by friends buffered participants’ emotional trauma caused by adverse effects of 
the disease and treatment. According to Deno et al. (2012), social support and being 
accepted by friends reduces both emotional and social burden of the disease and treatment. 
Isaksson et al. (2016) also found that social support was crucial for patients with head and 
neck cancer to cope with consequences of the disease and treatment. Participants agreed 
that sharing information and experiences with other cancer patients decreased their 
emotional distress and gave them hope. In addition, receiving a social grant relieved the 
financial pressure some of the participants experienced. In support of these findings, Lang et 
al. (2013), in a systematic literature review focusing on psychosocial experiences of the head 
and neck cancer, stated that sharing experiences of the disease and treatment reduced 
patients’ emotional suffering. Although receiving a social grant relieved participants of their 
financial burden caused by the disease and treatment, no evidence was found in literature to 
support the findings. 
The participants agreed that having hope, being positive and having faith in God and prayer 
support helped them to cope with their cancer journey. According to Garssen and Visser 
(2016), spirituality plays an important role in mental well-being for patients with head and 
neck cancer and it has a positive influence on quality of life. Being positive and having hope 
reduces the emotional burden for cancer patients (Deno et al. 2012). Having faith in God is 
known to have a positive influence on patients’ experiences of disease and treatment. An 
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Indian study, on coping with diagnosis and treatment of head and neck cancer, showed that 
hope and belief in God was an important coping mechanism for these patients (Jagannathan 
and Juvva 2016). In contrast, some participants in the current study experienced spiritual 
distress, to the extent that some doubted the existence of God because they felt that their 
prayers were not being answered. Unfortunately, no evidence from literature was found to 
support the findings.  
    
4.5 SUMMARY  
This chapter focused on the findings and discussion of the study. Chapter 5 will justify and 
conclude the study including the recommendations, limitations and a reflection of the 
researchers. 
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CHAPTER 5: 
JUSTIFICATION, LIMITATIONS, RECOMMENDATIONS AND CONCLUSION 
 
5.1 INTRODUCTION  
The previous chapter contained the findings and discussion. This chapter will focus on the 
justification of the study, limitations, recommendations and conclusion, with the aim of 
presenting an evaluation of the study by outlining the justification and limitations. Finally, the 
recommendations, researcher reflection and the conclusion will be provided. 
 
5.2 JUSTIFICATION  
The justification of the study will be based on the initial purpose of the study, which was to 
describe the experiences of patients living with head and neck cancer treated at an academic 
hospital in Gauteng.  
Chapter 3 detailed the methods and design for the study and Chapter 4 presented the 
findings and discussion of the experiences of patients living with cancer of the head and 
neck. The experiences of head and neck cancer patients treated at an academic hospital 
were established and the feature was presented in terms of two themes: living with the 
consequences of disease and treatment and coping with changed life. Therefore, the 
purpose of the study has been achieved and it can be concluded that the study is justified. 
 
5.3 LIMITATIONS OF THE STUDY 
The findings of qualitative studies cannot be extended to a wider population. The study was a 
qualitative study and such studies do not reflect only the truth about a phenomenon, as there 
could be multiple interpretations of the raw data. 
    
5.4 RECOMMENDATIONS    
A holistic and individualised patient need assessment for head and neck cancer patients 
would assist nurses in identifying patients’ needs and an individualised plan of care would 
help these patients to cope with symptoms and complications of the disease and treatment. 
Nurses should also develop educational materials, such as patients’ information leaflets and 
brochures, focusing on self-care management to assist these patients to cope with physical, 
emotional and social consequences of the disease and treatment. Routine health education 
and pre-treatment counselling of patients focussing on the treatment related side effects and 
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their management would also help these patients to cope with the emotional and physical 
challenges caused by the disease and treatment. A study on experiences of caregivers and 
significant others would add more information in order to clarify the phenomenon 
investigated. The nursing education syllabus for oncology students should include the 
development and implementation of patients’ education tools regarding self-care 
management of complications and side effects the head and neck cancer and treatment.  
 
5.5 INVESTIGATOR’S REFLECTION ON HIS EXPERIENCE     
Reflection is a process of revisiting one’s thoughts, feeling and actions after an encounter 
with an event with the purpose of making sense of the experience, and it is an important part 
of experiential learning (Boud et al. 2013). Therefore, I would like to take this chance to share 
my experience of this study with the reader.    
Despite the fact I worked with head and neck cancer patients and I knew some physical 
consequences of the disease and treatment, I did not know how the patients felt about the 
side effects or how they experienced life in their communities with these consequences. I felt 
awful seeing participants struggling to speak and having their faces covered with masks due 
to disfigurement. I felt deeply sorry for the participants as they narrated their traumatic 
experiences, such as loss of their beloved ones, loss of their body parts and living with 
tracheostomies and feeding tubes.  I shared their emotion as they vented their feelings by 
crying and shedding tears. 
Some participants had to cry while reflecting on their experiences during the interview and I 
allowed them to cry for some time. After crying I asked them whether they wanted to be 
referred to someone in order to help them with their emotional concerns and all affected 
participants said that the emotions were for the moment and it was okay for them to continue 
with the interview.  
I met all the 18 participants on their follow up visits and an initial trust relationship was 
embellished during the time they were completing their radiotherapy hence the participants 
were free to entrust me with their experiences. Nineteen patients were contacted to consider 
participation in the study, but one patient refused to be audio recorded and cancelled the 
consent to participate. I felt humiliated, but later I realised the patient was exercising her 
autonomy and I was not prepared emotionally for the refusal. Given a similar situation in 
future, I realise that psychological preparation prior to data gathering is the tool to handle 
such situations.  
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5.6 CONCLUSION  
Living with cancer of the head and neck is not easy. The lives the participants knew before 
they became sick changed and became a living hell. They had to live the effects of the 
disease and treatment, which had a devastating effect on their financial burden. Eating 
became a major challenge and some of the participants struggled to communicate, whilst 
others had to live with facial disfigurement. Some were ridiculed and some isolated 
themselves from social contact. However, receiving support from family and friends and their 
faith in God assisted them to live this changed life.  
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ANNEXURE B: INFORMATION LEAFLET                
 
Good day,  
My name is Samuel Bingo, I am a postgraduate student for masters of science in Nursing 
(Oncology and Palliative Care) in the Department of Nursing Education, at the University of 
the Witwatersrand. I write to invite you to consider participating in a research study entitled 
‘Living with the cancer of head and neck: experiences of patients with head and neck cancer 
treated an academic hospital in Gauteng.’ It is very necessary for you to understand the 
explanations below regarding the purpose of the study, risks, benefits and your rights before 
you agree to participate. Should you have any question, you are free to ask me in person. 
You should agree to participate only if you are satisfied about procedures involved. Please 
do not agree to participate if you are engaged in another study at present. Should you decide 
to take part in this study, you will be required to sign this document as a proof of agreement 
and you will get a copy. 
Purpose 
As a patient who is being treated for head and neck cancer, you are asked to consider taking 
part in this study. The purpose of the study is to describe the experiences of patients living 
with head and neck cancer in order to gather information which will help the health care 
workers to provide the best care to the patients with head and neck cancer.  
Procedures 
If you agree to participate in this study, you will be required to attend a 30-45 minutes in-
depth interview, where you will be asked to tell a story about your life after the diagnosis of 
head and neck cancer. You will be asked some more questions to clarify your story where 
necessary. The interviews will be done in a private room to ensure that no one will hear your 
story apart the interviewer.  
Your rights  
You have the right to self-determination, therefore, participation in this study is voluntarily 
and your decision not to participate will not attract any penalty or denial of any privileges.  
You will be given a number which will be used instead of your name throughout the interview 
and in the report in order to maintain your right to privacy and confidentiality. Your 
information will be treated with high level of confidentiality. However, your information might 
be inspected by the Supervisor and the University of the Witwatersrand, Human Research 
Ethics Committee (HREC).   
Benefits of the study 
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This study may not have direct benefit for you as a participant, however the information will 
help health workers in planning of care for other patient with head and neck cancer.  
Risks  
In my opinion, there should be no risk to you as a participant in narrating your life story after 
the diagnosis of head and neck cancer. However, should you have any discomfort regarding 
sharing your story at any point, do not hesitate to inform me and you will be referred to 
appropriate people for further care. 
Ethical approval 
This study protocol has been submitted to the University of the Witwatersrand, Human 
Research Ethics Committee (HREC) and written approval has been granted by that committee. 
An approval was also sort from the research site and an approval was granted. This study is 
partly sponsored by the government of Malawi and partly by the researcher himself. There is 
no influence from the sponsor that may bias my actions in this study. 
 
Reimbursement for the study participation 
You will not be paid for participating in this study, however your transport may be reimbursed 
when necessary. 
 
Sources of information 
If you need further clarification or question about the participating this study, you are free to 
contact me (Samuel Bingo) at 0613410071 or write email to josephbingo26@gmail.com  at 
any time. If you want any information regarding your rights as a research participant, or 
complaints regarding this research study, you may contact Prof. Cleaton-Jones, Chairperson 
of the University of the Witwatersrand, Human Research Ethics Committee (HREC), which is 
an independent committee established to help protect the rights of research participants at 
(011) 717 2301. 
 
Yours faithfully  
 
Samuel Bingo 
Date_______________ 
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ANNEXURE C: INFORMED CONSENT FOR PARTICIPATION    
   
I hereby confirm that I have been informed by the researcher, .........................(name of the 
researcher) about the nature, conduct, benefits and risks of study entitled ‘Living with the 
cancer of head and neck: experiences of patients with head and neck cancer treated an 
academic hospital in Gauteng. 
I have also received, read and understood the above written information (Participant 
Information Leaflet and Informed Consent) regarding the research study.  
I am aware that the results of the study, including personal details regarding my sex, age, date 
of birth, initials and diagnosis will be anonymously processed into a study report.  
In view of the requirements of research, I agree that the data gathered during this study can 
be accessed by the supervisor and other Authorities.  
I may, at any stage, without prejudice, withdraw my consent and participation in the study. 
I have had sufficient opportunity to ask questions and (of my own free will) declare myself 
prepared to participate in the study.  
 
Participant: 
 
Printed Name     Signature / Mark or Thumbprint  Date and Time 
 
I, ...................................(Name of the researcher) herewith confirm that the above participant 
has been fully informed about the nature, conduct and risks of the above study. 
Researcher: 
 
Printed Name   Signature     Date and Time 
 
WITNESS (If applicable): 
 
Printed Name    Signature    Date and Time
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ANNEXURE D: INFORMATION LEFLET FOR VOICE RECORDING 
 
Good day, 
My name is Samuel Bingo, a postgraduate student in the department of nursing education at 
the University of Witwatersrand. I would like to inform you that this study involves the audio 
recording of your interview with the researcher. Neither your name nor any other identifying 
information will be associated with the audio recording or the transcript. Only the research 
and the supervisor will be able to listen to the recordings. The recording will be treated with 
high level of confidentiality. 
The recordings will be transcribed by the researcher and erased once the transcriptions are 
checked for accuracy. Transcripts of your interview may be reproduced in whole or in part for 
use in presentations or written products that result from this study. Neither your name nor 
any other identifying information such as your voice will be used in presentations or in written 
products resulting from the study. 
You have the right to refuse the audio recording of this interview for any reason without being 
penalised.  
If you have any question regarding recording of your interview with the researcher, please 
ask me (Samuel Bingo) now or you are free to contact me at 0613410071.  
It is important that you understand the information on this leaflet before you agree by signing 
the consent form. 
 
Yours faithfully 
 
Samuel Bingo  
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ANNEXURE E: INFORMED CONSENT FOR AUDIO RECORDING   
      
I hereby confirm that I have been informed by the researcher, .........................(name of the 
researcher) about the audio recording of the interview between the me (the participant) and 
the researcher. 
I have also received, read and understood the above written information (Participant 
Information Leaflet and Informed Consent) regarding the audio recording of the interview.  
I am aware that my name or any other identifying information will not be associated with the 
audio recording or the transcript.  
In view of the requirements of research, I agree that the audio recordings recorded during this 
interview can be accessed by the supervisor and the researcher.  
I may, without prejudice, deny the audio recording withdraw my consent and participation in 
the study. 
I have had sufficient opportunity to ask questions and (of my own free will) declare myself 
prepared to be recorded during this interview.  
 
Participant: 
 
Printed Name     Signature / Mark or Thumbprint  Date and Time 
I, ...................................(Name of the researcher) herewith confirm that the above participant 
has been fully informed about the audio recording of the interview between the above 
participant and the researcher. 
Researcher: 
 
Printed Name   Signature     Date and Time 
 
Witness: 
 
Printed Name    Signature    Date and Time
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ANNEXURE F: DEMOGRAPHIC DATA QUESTIONAIRE  
 
LING WITH CANCER OF HEAD AND NECK: A QUALITATIVE INQUIRY INTO 
EXPERIENCES OF PATIENTS TREATED AT AN ACADEMIC HOSPITAL IN GAUTENG. 
1. Participant number…………… 
2. Diagnosis……………………… 
3. Duration of sickness………… 
4. Treatment received  
Surgery  
Radiotherapy  
chemotherapy  
 
Others specify………………… 
 
5. Age:    
 
 
 
 
 
 
 
 
6. Gender:  
     
 
 
 
7. Population group: 
8.  
 
 
 
 
 
 
Others, specify……………………… 
9. Marital status: 
 
 
 
 
 
 
10. Highest Level of education 
 
 
 
 
 
 
11. Employment 
 
 
 
 
 
12. Income: 
Above R779  
Less than R779  
18-25  
26-33  
34-41  
42-49  
50-57  
58-65  
65-72  
72-79  
Male  
Female  
Transgender  
White  
Asian  
Black  
Coloured  
Single  
Married   
Divorced  
Widowed  
Separated  
Grade 1-4  
Grade 5-8  
High school  
Degree  
Postgraduate  
Full time   
Part time  
unemployed  
Retired  
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ANNEXURE G: POSTGRADUATE COMMITEE TITLE APPROVAL LETTER 
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ANNEXURE H:  HUMAN RESEARCH ETHEICS CLEARANCE CERTIFICATE 
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ANNEXURE I: RESEARCH SITE APPROVAL 
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ANNEXURE J: LANGUAGE EDIT CERTIFICATE 
 
 
 
 
